RGD DISEASE ONTOLOGY - ANNOTATIONS |
|
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
|
Term: | Bacterial Infections and Mycoses |
|
Accession: | DOID:9004384
|
browse the term
|
Definition: | Infections caused by bacteria and fungi, general, specified, or unspecified. |
Synonyms: | primary_id: | MESH:D001423 |
| subset: | RGD_JBrowse_slim |
|
|
|
G |
Irak4 |
interleukin-1 receptor-associated kinase 4 |
susceptibility |
ISO |
deficiency of IRAK4/extracellular pyogenic bacterial and fungal infections, OMIM:607676 |
RGD |
PMID:12637671 |
RGD:1600199 |
NCBI chr 7:125,682,502...125,708,294
Ensembl chr 7:125,682,488...125,717,837
|
|
|
G |
Abcb1a |
ATP binding cassette subfamily B member 1A |
treatment |
ISO |
DNA:haplotype: :3435T>C((rs1045642), 2677T>G (rs2032582) (human) DNA:SNP: : rs10276036(human) |
RGD |
PMID:23372834 PMID:24517233 |
RGD:39456119, RGD:11098698 |
NCBI chr 4:26,312,403...26,488,456
Ensembl chr 4:25,158,362...25,442,709
|
|
G |
Arhgap44 |
Rho GTPase activating protein 44 |
disease_progression |
ISO |
DNA:SNPs, haplotype:intron, exon: (rs2072255, rs2072254) (human) DNA:SNP:intron: (rs2072255) (human) |
RGD |
PMID:28069446 PMID:21107268 |
RGD:401901288, RGD:401901289 |
NCBI chr10:49,655,583...49,822,876
Ensembl chr10:49,655,584...49,824,297
|
|
G |
Bst2 |
bone marrow stromal cell antigen 2 |
|
ISO |
DNA:SNPs: : |
RGD |
PMID:26885809 |
RGD:14398494 |
NCBI chr16:18,216,605...18,220,979
Ensembl chr16:18,217,407...18,220,979
|
|
G |
Ccl4 |
C-C motif chemokine ligand 4 |
|
ISO |
DNA:SNP:3' utr:rs1719153 (human) |
RGD |
PMID:16773571 |
RGD:5683896 |
NCBI chr10:68,466,394...68,468,229
Ensembl chr10:68,452,052...68,468,231
|
|
G |
Ccr5 |
C-C motif chemokine receptor 5 |
|
ISO |
ClinVar Annotator: match by term: Acquired immunodeficiency syndrome, delayed progression to |
ClinVar |
PMID:9742978 PMID:12610055 PMID:12815099 |
|
NCBI chr 8:123,752,423...123,757,538
Ensembl chr 8:123,752,325...123,759,260
|
|
G |
Cd209d |
CD209d molecule |
disease_progression |
ISO |
associated with factor VIII deficiency; DNA:SNP:promoter: g.-139C>T (rs2287886) (human) |
RGD |
PMID:17530998 |
RGD:39939010 |
NCBI chr12:1,891,109...1,897,559
Ensembl chr12:1,891,113...1,901,171
|
|
G |
Cd4 |
Cd4 molecule |
|
ISO |
associated with drug dependence; protein:increased expression:temporal lobe (human) |
RGD |
PMID:16873198 |
RGD:407420271 |
NCBI chr 4:157,668,878...157,695,366
Ensembl chr 4:157,668,878...157,695,191
|
|
G |
Cd40lg |
CD40 ligand |
treatment |
ISO |
|
RGD |
PMID:9499800 |
RGD:11344976 |
NCBI chr X:135,127,052...135,138,768
Ensembl chr X:135,126,969...135,138,306
|
|
G |
Cd68 |
Cd68 molecule |
|
ISO |
associated with drug dependence; protein:increased expression:temporal lobe (human) |
RGD |
PMID:16873198 |
RGD:407420271 |
NCBI chr10:54,381,814...54,383,693
Ensembl chr10:54,381,815...54,383,697
|
|
G |
Cd8a |
CD8 subunit alpha |
|
ISO |
associated with drug dependence; protein:increased expression:temporal lobe (human) |
RGD |
PMID:16873198 |
RGD:407420271 |
NCBI chr 4:103,365,804...103,370,041
Ensembl chr 4:103,365,804...103,370,040
|
|
G |
Ercc2 |
ERCC excision repair 2, TFIIH core complex helicase subunit |
susceptibility |
ISO |
DNA:polymorphism:exon:p.K751Q(human) |
RGD |
PMID:20127180 |
RGD:5688740 |
NCBI chr 1:79,033,342...79,047,102
Ensembl chr 1:79,033,326...79,047,102
|
|
G |
Ido1 |
indoleamine 2,3-dioxygenase 1 |
|
ISO |
associated with pulmonary tuberculosis;protein:increased expression:blood (human) |
RGD |
PMID:32369456 |
RGD:39939073 |
NCBI chr16:67,430,654...67,442,726
Ensembl chr16:67,430,578...67,442,730
|
|
G |
Ifna1 |
interferon, alpha 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:9612607 |
|
NCBI chr 5:103,097,356...103,097,925
Ensembl chr 5:103,097,356...103,097,925
|
|
G |
Ifng |
interferon gamma |
|
ISO |
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Acquired immunodeficiency syndrome, rapid progression to |
CTD ClinVar |
PMID:9612607 PMID:12854077 |
|
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
|
|
G |
Igf2 |
insulin-like growth factor 2 |
|
ISO |
protein:decreased expression:plasma |
RGD |
PMID:11232005 |
RGD:5509969 |
NCBI chr 1:197,814,409...197,831,802
Ensembl chr 1:197,814,410...197,823,018
|
|
G |
Il2 |
interleukin 2 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:9861562 |
|
NCBI chr 2:121,932,968...121,937,672
Ensembl chr 2:120,004,862...120,009,566
|
|
G |
Kir3dl1 |
killer cell immunoglobulin like receptor, three Ig domains and long cytoplasmic tail 1 |
severity |
ISO |
DNA:missense mutation:cds: p.I47V (rs643347) (human) |
RGD |
PMID:29461980 |
RGD:38676267 |
NCBI chr 1:69,715,529...69,754,050
Ensembl chr 1:69,715,535...69,754,050
|
|
G |
Ncr1 |
natural cytotoxicity triggering receptor 1 |
|
ISO |
protein:decreased expression:peripheral blood mononuclear cell,natural killer cell (human) |
RGD |
PMID:27382604 |
RGD:40818276 |
NCBI chr 1:69,614,744...69,622,594
Ensembl chr 1:69,616,601...69,660,558
|
|
G |
Ncr3 |
natural cytotoxicity triggering receptor 3 |
|
ISO |
protein:decreased expression:peripheral blood mononuclear cell,natural killer cell (human) |
RGD |
PMID:27382604 |
RGD:40818276 |
NCBI chr20:3,637,242...3,643,748
Ensembl chr20:3,638,240...3,643,799
|
|
G |
RT1-CE15 |
RT1 class I, locus CE15 |
susceptibility |
ISO |
DNA:polymorphism: :HLA-A31 |
RGD |
PMID:19030725 |
RGD:36049809 |
NCBI chr20:3,275,575...3,279,074
Ensembl chr20:3,264,172...3,279,563 Ensembl chr20:3,264,172...3,279,563
|
|
G |
RT1-CE16 |
RT1 class I, locus CE16 |
susceptibility |
ISO |
DNA:polymorphism: :HLA-A31 |
RGD |
PMID:19030725 |
RGD:36049809 |
NCBI chr20:3,257,109...3,260,747
Ensembl chr20:3,257,123...3,279,563
|
|
G |
Tnf |
tumor necrosis factor |
|
ISO |
|
RGD |
PMID:8548330 |
RGD:12904035 |
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tnfrsf1a |
TNF receptor superfamily member 1A |
|
ISO |
|
RGD |
PMID:8548330 |
RGD:12904035 |
NCBI chr 4:158,150,815...158,163,592
Ensembl chr 4:158,150,820...158,163,591
|
|
G |
Tnfrsf1b |
TNF receptor superfamily member 1B |
|
ISO |
|
RGD |
PMID:8548330 |
RGD:12904035 |
NCBI chr 5:157,070,642...157,104,216
Ensembl chr 5:157,070,642...157,104,206
|
|
G |
Vdr |
vitamin D receptor |
|
ISO |
|
GAD |
PMID:15118671 |
RGD:1331525 |
NCBI chr 7:128,987,981...129,037,677
Ensembl chr 7:128,987,981...129,037,677
|
|
|
G |
Cd163 |
CD163 molecule |
|
ISO |
protein:increased expression:lung (pig) |
RGD |
PMID:33287430 |
RGD:127345134 |
NCBI chr 4:157,085,080...157,118,470
Ensembl chr 4:157,085,093...157,117,878
|
|
G |
Defb1 |
defensin beta 1 |
|
IEP |
mRNA:increased expression:gingival epithelium |
RGD |
PMID:17076783 |
RGD:4892269 |
NCBI chr16:70,298,862...70,313,604
Ensembl chr16:70,298,863...70,313,604
|
|
|
G |
Adrb2 |
adrenoceptor beta 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27400929 |
|
NCBI chr18:55,642,459...55,644,501
Ensembl chr18:55,502,903...55,644,512
|
|
G |
Epo |
erythropoietin |
treatment |
ISO |
|
RGD |
PMID:20818790 |
RGD:10395393 |
NCBI chr12:19,204,258...19,207,948
Ensembl chr12:19,204,508...19,207,946
|
|
G |
Gc |
GC, vitamin D binding protein |
|
ISO |
associated with HIV Infections;protein:increased expression:cerebrospinal fluid: |
RGD |
PMID:17929958 |
RGD:5509882 |
NCBI chr14:18,632,146...18,667,563
Ensembl chr14:18,632,135...18,667,567
|
|
G |
Il1b |
interleukin 1 beta |
|
IEP |
protein:increased expression:neocortex |
RGD |
PMID:17678975 |
RGD:1626641 |
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Insr |
insulin receptor |
severity |
ISO |
protein:increased expression:cerebrospinal fluid, plasma |
RGD |
PMID:22629383 |
RGD:10403033 |
NCBI chr12:1,193,193...1,330,976
Ensembl chr12:1,197,100...1,330,883
|
|
G |
Irs1 |
insulin receptor substrate 1 |
severity |
ISO |
protein:decreased tyrosine phosphorylation:cerebrospinal fluid, leukocyte |
RGD |
PMID:22629383 |
RGD:10403033 |
NCBI chr 9:83,552,964...83,605,797
Ensembl chr 9:83,548,944...83,606,122
|
|
G |
Nefl |
neurofilament light chain |
|
ISO |
associated with HIV Seropositivity;protein:increased expression:plasma, CSF (human) protein:increased expression:CSF (human) |
RGD |
PMID:30105502 PMID:27400930 |
RGD:127284876, RGD:127284885 |
NCBI chr15:42,301,920...42,305,793
Ensembl chr15:42,301,916...42,305,793
|
|
G |
Npy |
neuropeptide Y |
severity |
ISO |
protein:increased expression:cerebrospinal fluid |
RGD |
PMID:8815163 |
RGD:10431910 |
NCBI chr 4:78,881,294...78,888,495
Ensembl chr 4:78,881,264...78,888,495
|
|
G |
Oprm1 |
opioid receptor, mu 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27400929 |
|
NCBI chr 1:43,160,057...43,413,409
Ensembl chr 1:43,160,057...43,413,409
|
|
G |
Pdgfb |
platelet derived growth factor subunit B |
|
ISO |
|
RGD |
PMID:21368226 |
RGD:6482787 |
NCBI chr 7:111,539,444...111,557,984
Ensembl chr 7:111,540,345...111,557,984
|
|
G |
Slc6a4 |
solute carrier family 6 member 4 |
|
ISO |
|
RGD |
PMID:25404050 |
RGD:38676266 |
NCBI chr10:61,824,208...61,858,924
Ensembl chr10:61,826,123...61,858,384
|
|
|
G |
Agtr1a |
angiotensin II receptor, type 1a |
|
ISO |
|
RGD |
PMID:2 |
RGD:1303381 |
NCBI chr17:34,173,446...34,226,892
Ensembl chr17:34,174,429...34,226,946
|
|
G |
Agtr2 |
angiotensin II receptor, type 2 |
|
ISO |
|
RGD |
PMID:2 |
RGD:1303381 |
NCBI chr X:112,119,876...112,124,060
Ensembl chr X:112,120,228...112,124,057
|
|
G |
Egf |
epidermal growth factor |
|
ISO |
|
RGD |
PMID:19357719 |
RGD:6906909 |
NCBI chr 2:218,219,408...218,302,359
Ensembl chr 2:218,219,415...218,302,064
|
|
G |
Hp |
haptoglobin |
|
ISO |
protein:increased expression:urine |
RGD |
PMID:19279121 |
RGD:11041816 |
NCBI chr19:37,539,626...37,544,178
Ensembl chr19:37,539,627...37,544,523
|
|
G |
Mtor |
mechanistic target of rapamycin kinase |
|
ISO |
|
RGD |
PMID:23678040 PMID:23678040 |
RGD:7245474, RGD:7245474 |
NCBI chr 5:158,884,856...158,994,311
Ensembl chr 5:158,884,804...158,994,311
|
|
G |
Myh9 |
myosin, heavy chain 9 |
|
ISO |
protein:decreased expression:glomerulus |
RGD |
PMID:22313957 |
RGD:6903274 |
NCBI chr 7:109,343,718...109,424,457
Ensembl chr 7:109,343,706...109,424,457
|
|
G |
Notch4 |
notch receptor 4 |
|
IEP |
protein: increased expression: kidney |
RGD |
PMID:20706108 |
RGD:6480788 |
NCBI chr20:4,160,362...4,184,466
Ensembl chr20:4,160,445...4,184,465
|
|
G |
Nphs1 |
NPHS1 adhesion molecule, nephrin |
treatment |
ISO |
|
RGD |
PMID:19188342 PMID:17229913 |
RGD:38596324, RGD:38599164 |
NCBI chr 1:85,720,812...85,749,079
Ensembl chr 1:85,720,812...85,749,078
|
|
|
G |
Klrk1 |
killer cell lectin like receptor K1 |
treatment |
ISO |
|
RGD |
PMID:23018378 |
RGD:39018554 |
NCBI chr 4:163,079,887...163,092,434
Ensembl chr 4:163,081,927...163,092,459
|
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:10861090 |
|
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
|
G |
Cd4 |
Cd4 molecule |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:9546790 |
|
NCBI chr 4:157,668,878...157,695,366
Ensembl chr 4:157,668,878...157,695,191
|
|
G |
Tnfrsf8 |
TNF receptor superfamily member 8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:9379333 |
|
NCBI chr 5:157,123,183...157,168,421
Ensembl chr 5:157,123,185...157,168,421
|
|
|
G |
Ccl17 |
C-C motif chemokine ligand 17 |
|
ISO |
associated with Cystic Fibrosis |
RGD |
PMID:17898016 |
RGD:4145612 |
NCBI chr19:10,202,128...10,203,903
Ensembl chr19:10,202,128...10,203,819
|
|
G |
Ccr1 |
C-C motif chemokine receptor 1 |
|
ISO |
|
RGD |
PMID:15951834 |
RGD:5688155 |
NCBI chr 8:123,556,286...123,561,841
|
|
G |
Ccr2 |
C-C motif chemokine receptor 2 |
|
ISO |
|
RGD |
PMID:10946288 |
RGD:8661731 |
NCBI chr 8:123,734,465...123,742,483
Ensembl chr 8:123,734,430...123,742,100
|
|
G |
Cftr |
CF transmembrane conductance regulator |
|
ISO |
DNA:mutations: : |
RGD |
PMID:11243954 |
RGD:4140482 |
NCBI chr 4:46,561,269...46,728,759
Ensembl chr 4:46,560,885...46,728,756
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
|
ISO |
|
RGD |
PMID:7743671 |
RGD:8547590 |
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
|
|
G |
Il1a |
interleukin 1 alpha |
|
ISO |
|
RGD |
PMID:8699818 |
RGD:7794730 |
NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822
|
|
G |
Mbl2 |
mannose binding lectin 2 |
susceptibility |
ISO |
Chronic Necrotizing Pulmonary Aspergillosis; DNA:missense mutation:exon:p.R52C (human) DNA:SNP:intron:1011G>A(human) |
RGD |
PMID:11474427 PMID:16487239 |
RGD:4889577, RGD:8693711 |
NCBI chr 1:228,016,439...228,024,736
|
|
G |
RT1-Bb |
RT1 class II, locus Bb |
susceptibility |
ISO |
associated with cystic fibrosis; DNA:polymorphisms: :DQB1*06:02, DQB1*02:01(human) |
RGD |
PMID:23278646 |
RGD:36049760 |
NCBI chr20:4,596,558...4,602,201
Ensembl chr20:4,596,559...4,607,597
|
|
G |
RT1-Db1 |
RT1 class II, locus Db1 |
susceptibility |
ISO |
associated with cystic fibrosis; DNA:polymorphisms: : |
RGD |
PMID:23278646 |
RGD:36049760 |
NCBI chr20:4,548,664...4,558,237
Ensembl chr20:4,548,666...4,558,258
|
|
G |
Tlr9 |
toll-like receptor 9 |
susceptibility |
ISO |
DNA:SNP:promoter:g.-1237T>C rs5743836 (human) |
RGD |
PMID:18275280 PMID:18936185 |
RGD:5130863, RGD:5130858 |
NCBI chr 8:106,864,680...106,868,796
Ensembl chr 8:106,864,680...106,868,796
|
|
G |
Tnf |
tumor necrosis factor |
|
ISO |
|
RGD |
PMID:8699818 |
RGD:7794730 |
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tnfrsf1a |
TNF receptor superfamily member 1A |
susceptibility |
ISO |
DNA:snps:5' utr, exon:g.-609G>T rs4149570, g.36A>G rs767455 (human) |
RGD |
PMID:20646338 |
RGD:5131174 |
NCBI chr 4:158,150,815...158,163,592
Ensembl chr 4:158,150,820...158,163,591
|
|
|
G |
Il1rl1 |
interleukin 1 receptor-like 1 |
treatment |
ISO |
mRNA:increased expression:brain: |
RGD |
PMID:24657070 PMID:23148283 |
RGD:11561855, RGD:40400713 |
NCBI chr 9:42,661,694...42,727,266
Ensembl chr 9:42,697,192...42,727,256
|
|
G |
Il33 |
interleukin 33 |
|
ISO |
protein:increased expression:brain: |
RGD |
PMID:23148283 PMID:24076431 |
RGD:40400713, RGD:40400715 |
NCBI chr 1:227,701,964...227,736,374
Ensembl chr 1:227,721,435...227,736,373
|
|
G |
Il5 |
interleukin 5 |
|
ISO |
|
RGD |
PMID:8361777 |
RGD:11354948 |
NCBI chr10:37,874,342...37,877,213
Ensembl chr10:37,874,342...37,877,213
|
|
G |
Mag |
myelin-associated glycoprotein |
disease_progression |
ISO |
|
RGD |
PMID:20399564 |
RGD:27226693 |
NCBI chr 1:86,148,227...86,163,726
Ensembl chr 1:86,148,228...86,163,656
|
|
G |
Mbp |
myelin basic protein |
disease_progression |
ISO |
|
RGD |
PMID:20399564 |
RGD:27226693 |
NCBI chr18:75,855,878...75,966,404
Ensembl chr18:75,855,878...75,966,404
|
|
G |
Mobp |
myelin-associated oligodendrocyte basic protein |
disease_progression |
ISO |
|
RGD |
PMID:20399564 |
RGD:27226693 |
NCBI chr 8:119,869,504...119,899,605
Ensembl chr 8:119,869,626...119,899,563
|
|
|
G |
Ccl20 |
C-C motif chemokine ligand 20 |
|
ISO |
protein:decreased expression:skin |
RGD |
PMID:17545018 |
RGD:7483603 |
NCBI chr 9:84,389,031...84,391,629
Ensembl chr 9:84,388,904...84,391,629
|
|
G |
Cd8a |
CD8 subunit alpha |
|
ISO |
mRNA:decreased expression:zone of skin (human) |
RGD |
PMID:25774455 |
RGD:36174028 |
NCBI chr 4:103,365,804...103,370,041
Ensembl chr 4:103,365,804...103,370,040
|
|
G |
Ctla4 |
cytotoxic T-lymphocyte-associated protein 4 |
|
ISO |
mRNA,protein:increased expression:multiple (human) |
RGD |
PMID:23754510 |
RGD:40400714 |
NCBI chr 9:62,318,874...62,325,978
Ensembl chr 9:62,319,312...62,324,963
|
|
G |
Foxp3 |
forkhead box P3 |
|
ISO |
mRNA,protein:increased expression:multiple (human) |
RGD |
PMID:23754510 |
RGD:40400714 |
NCBI chr X:14,908,494...14,924,994
Ensembl chr X:14,908,494...14,923,838
|
|
G |
Ifna1 |
interferon, alpha 1 |
treatment |
ISO |
|
RGD |
PMID:25774455 |
RGD:36174028 |
NCBI chr 5:103,097,356...103,097,925
Ensembl chr 5:103,097,356...103,097,925
|
|
G |
Il10 |
interleukin 10 |
|
ISO |
mRNA,protein:increased expression:multiple (human) |
RGD |
PMID:23754510 |
RGD:40400714 |
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
|
|
G |
Il12b |
interleukin 12B |
treatment |
ISO |
protein:decreased expression:peripheral blood mononuclear cells (human) |
RGD |
PMID:16114559 PMID:23754510 |
RGD:7829774, RGD:40400714 |
NCBI chr10:28,888,832...28,903,802
Ensembl chr10:28,893,008...28,902,903
|
|
G |
Il2 |
interleukin 2 |
|
ISO |
protein:decreased expression:peripheral blood mononuclear cells (human) |
RGD |
PMID:23754510 |
RGD:40400714 |
NCBI chr 2:121,932,968...121,937,672
Ensembl chr 2:120,004,862...120,009,566
|
|
G |
Il21 |
interleukin 21 |
|
ISO |
protein:decreased expression:blood serum (human) |
RGD |
PMID:31414711 |
RGD:127285371 |
NCBI chr 2:120,117,105...120,127,012
Ensembl chr 2:120,119,444...120,126,996
|
|
G |
Il4 |
interleukin 4 |
treatment |
ISO |
protein:increased expression:peripheral blood mononuclear cells (human) |
RGD |
PMID:16114559 PMID:23754510 |
RGD:7829774, RGD:40400714 |
NCBI chr10:37,771,203...37,776,750
Ensembl chr10:37,771,203...37,776,750
|
|
G |
Il6 |
interleukin 6 |
|
ISO |
protein:decreased expression:peripheral blood mononuclear cells (human) |
RGD |
PMID:23754510 |
RGD:40400714 |
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Klrk1 |
killer cell lectin like receptor K1 |
|
ISO |
mRNA,protein:decreased expression:multiple (human) |
RGD |
PMID:23754510 |
RGD:40400714 |
NCBI chr 4:163,079,887...163,092,434
Ensembl chr 4:163,081,927...163,092,459
|
|
G |
Mapk8 |
mitogen-activated protein kinase 8 |
treatment |
ISO |
mRNA:increased expression:zone of skin (human) |
RGD |
PMID:25774455 |
RGD:36174028 |
NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981
|
|
G |
Myd88 |
MYD88, innate immune signal transduction adaptor |
|
ISO |
mRNA,protein:increased expression:multiple (human) |
RGD |
PMID:23754510 |
RGD:40400714 |
NCBI chr 8:119,074,439...119,078,508
Ensembl chr 8:119,074,437...119,079,415
|
|
G |
Ncr1 |
natural cytotoxicity triggering receptor 1 |
|
ISO |
mRNA,protein:decreased expression:multiple (human) |
RGD |
PMID:23754510 |
RGD:40400714 |
NCBI chr 1:69,614,744...69,622,594
Ensembl chr 1:69,616,601...69,660,558
|
|
G |
Pdcd1 |
programmed cell death 1 |
|
ISO |
mRNA,protein:increased expression:multiple (human) |
RGD |
PMID:23754510 |
RGD:40400714 |
NCBI chr 9:94,418,786...94,431,945
Ensembl chr 9:94,418,791...94,431,937
|
|
G |
Ptpn11 |
protein tyrosine phosphatase, non-receptor type 11 |
|
ISO |
protein:increased expression:foreskin |
RGD |
PMID:18543080 |
RGD:39128248 |
NCBI chr12:35,365,436...35,424,925
Ensembl chr12:35,383,144...35,424,925
|
|
G |
Ptpn6 |
protein tyrosine phosphatase, non-receptor type 6 |
|
ISO |
protein:increased expression:foreskin |
RGD |
PMID:18543080 |
RGD:39128248 |
NCBI chr 4:157,526,034...157,550,783
Ensembl chr 4:157,526,035...157,550,984
|
|
G |
Serpinf1 |
serpin family F member 1 |
disease_progression |
ISO |
mRNA, protein:decreased expression:skin of body (human) |
RGD |
PMID:23569025 |
RGD:27226706 |
NCBI chr10:60,250,198...60,262,593
Ensembl chr10:60,249,708...60,262,646
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
|
ISO |
mRNA,protein:increased expression:multiple (human) |
RGD |
PMID:23754510 |
RGD:40400714 |
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
|
|
G |
Tlr2 |
toll-like receptor 2 |
|
ISO |
mRNA,protein:increased expression:multiple (human) |
RGD |
PMID:23754510 |
RGD:40400714 |
NCBI chr 2:169,200,620...169,206,819
Ensembl chr 2:169,197,419...169,206,630
|
|
G |
Tlr3 |
toll-like receptor 3 |
|
ISO |
mRNA,protein:increased expression:multiple (human) |
RGD |
PMID:23754510 |
RGD:40400714 |
NCBI chr16:46,821,980...46,837,900
Ensembl chr16:46,822,039...46,836,545
|
|
G |
Tlr4 |
toll-like receptor 4 |
|
ISO |
mRNA,protein:increased expression:multiple (human) |
RGD |
PMID:23754510 |
RGD:40400714 |
NCBI chr 5:80,145,867...80,159,501
Ensembl chr 5:80,145,826...80,159,628
|
|
G |
Tlr7 |
toll-like receptor 7 |
|
ISO |
mRNA,protein:increased expression:multiple (human) |
RGD |
PMID:23754510 |
RGD:40400714 |
NCBI chr X:27,027,380...27,054,309
Ensembl chr X:27,027,425...27,054,754
|
|
G |
Tlr8 |
toll-like receptor 8 |
|
ISO |
mRNA,protein:increased expression:multiple (human) |
RGD |
PMID:23754510 |
RGD:40400714 |
NCBI chr X:27,091,780...27,116,092
Ensembl chr X:27,091,778...27,116,549
|
|
G |
Tlr9 |
toll-like receptor 9 |
|
ISO |
mRNA,protein:increased expression:multiple (human) |
RGD |
PMID:23754510 |
RGD:40400714 |
NCBI chr 8:106,864,680...106,868,796
Ensembl chr 8:106,864,680...106,868,796
|
|
G |
Tnf |
tumor necrosis factor |
|
ISO |
protein:increased expression:peripheral blood mononuclear cells (human) |
RGD |
PMID:23754510 |
RGD:40400714 |
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tnfrsf18 |
TNF receptor superfamily member 18 |
|
ISO |
mRNA,protein:increased expression:multiple (human) |
RGD |
PMID:23754510 |
RGD:40400714 |
NCBI chr 5:166,618,461...166,622,353
Ensembl chr 5:166,618,969...166,622,353
|
|
|
G |
Antxr2 |
ANTXR cell adhesion molecule 2 |
|
IDA |
|
RGD |
PMID:17054395 |
RGD:1599126 |
NCBI chr14:11,541,718...11,682,110
Ensembl chr14:11,541,772...11,682,094
|
|
G |
Elane |
elastase, neutrophil expressed |
|
ISO |
protein:increased expression:plasma: |
RGD |
PMID:19049643 |
RGD:10450550 |
NCBI chr 7:9,817,251...9,819,174
Ensembl chr 7:9,817,252...9,819,100
|
|
G |
Il1b |
interleukin 1 beta |
disease_progression |
ISO |
mRNA:decreased expression:multiple (mouse) |
RGD |
PMID:19075243 |
RGD:40902812 |
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Rnasel |
ribonuclease L |
severity |
ISO |
|
RGD |
PMID:19075243 |
RGD:40902812 |
NCBI chr13:65,894,990...65,910,354
Ensembl chr13:65,901,459...65,908,704
|
|
G |
Tnf |
tumor necrosis factor |
disease_progression |
ISO |
protein:decreased expression:multiple (mouse) |
RGD |
PMID:19075243 |
RGD:40902812 |
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,622,011...3,624,629
|
|
|
G |
Alb |
albumin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:5108595 PMID:5109917 PMID:5536438 |
|
NCBI chr14:17,891,564...17,907,043
Ensembl chr14:17,607,381...17,622,836
|
|
G |
Il6 |
interleukin 6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:10888991 |
|
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,213,394...5,219,178
|
|
|
G |
Ager |
advanced glycosylation end product-specific receptor |
|
ISO |
DNA:SNP:promoter:-374T>A (human) |
RGD |
PMID:22114731 |
RGD:8695981 |
NCBI chr20:4,148,150...4,151,361
Ensembl chr20:4,147,890...4,151,078
|
|
G |
Ccl19 |
C-C motif chemokine ligand 19 |
|
ISO |
associated with Neutropenia;mRNA:increased expression:lung |
RGD |
PMID:19783686 |
RGD:5130908 |
NCBI chr 5:56,963,364...56,965,308
Ensembl chr 5:56,963,364...56,965,308
|
|
G |
Ccr7 |
C-C motif chemokine receptor 7 |
|
ISO |
associated with Neutropenia |
RGD |
PMID:19783686 |
RGD:5130908 |
NCBI chr10:84,098,193...84,108,309
Ensembl chr10:84,097,381...84,108,309
|
|
G |
Cd209d |
CD209d molecule |
|
ISO |
|
RGD |
PMID:21381282 |
RGD:5131183 |
NCBI chr12:1,891,109...1,897,559
Ensembl chr12:1,891,113...1,901,171
|
|
G |
Cftr |
CF transmembrane conductance regulator |
severity |
ISO |
|
RGD |
PMID:22135344 |
RGD:35673332 |
NCBI chr 4:46,561,269...46,728,759
Ensembl chr 4:46,560,885...46,728,756
|
|
G |
Clec1a |
C-type lectin domain family 1, member A |
susceptibility |
ISO |
ClinVar Annotator: match by term: Aspergillosis, susceptibility to CTD Direct Evidence: marker/mechanism |
OMIM ClinVar CTD |
PMID:25741868 PMID:29489751 |
|
NCBI chr 4:162,875,360...162,902,571
Ensembl chr 4:162,877,346...162,901,247
|
|
G |
Clec7a |
C-type lectin domain containing 7A |
|
ISO |
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: CLEC7A-related condition |
CTD OMIM ClinVar |
PMID:19864674 PMID:20807886 PMID:24033266 PMID:25741868 PMID:28492532 |
|
NCBI chr 4:162,902,731...162,913,931
Ensembl chr 4:162,902,732...162,913,897
|
|
G |
Crp |
C-reactive protein |
treatment |
ISO |
|
RGD |
PMID:20879853 |
RGD:9495929 |
NCBI chr13:85,135,384...85,175,178
Ensembl chr13:85,124,977...85,175,178
|
|
G |
Il15 |
interleukin 15 |
|
ISO |
DNA:polymorphism (human) |
RGD |
PMID:16893395 |
RGD:4981337 |
NCBI chr19:25,640,025...25,706,818
Ensembl chr19:25,640,251...25,706,820
|
|
G |
Mbl1 |
mannose binding lectin 1 |
susceptibility |
ISO |
|
RGD |
PMID:20064561 |
RGD:8694071 |
NCBI chr16:17,029,146...17,035,187
Ensembl chr16:17,029,118...17,035,174
|
|
G |
Mbl2 |
mannose binding lectin 2 |
susceptibility |
ISO |
|
RGD |
PMID:20064561 |
RGD:8694071 |
NCBI chr 1:228,016,439...228,024,736
|
|
G |
S100b |
S100 calcium binding protein B |
|
ISO |
DNA:SNP: :427C>T (human) |
RGD |
PMID:22114731 |
RGD:8695981 |
NCBI chr20:12,372,866...12,381,619
Ensembl chr20:12,372,881...12,394,743
|
|
G |
Tlr1 |
toll-like receptor 1 |
susceptibility |
ISO |
DNA:SNPs: :p.R80T, p.N248S (human) |
RGD |
PMID:16461792 |
RGD:4889535 |
NCBI chr14:43,384,127...43,396,765
Ensembl chr14:43,384,932...43,397,125
|
|
G |
Tlr2 |
toll-like receptor 2 |
|
ISO |
mRNA:increased expression:lung |
RGD |
PMID:19781388 |
RGD:4145322 |
NCBI chr 2:169,200,620...169,206,819
Ensembl chr 2:169,197,419...169,206,630
|
|
G |
Tlr6 |
toll-like receptor 6 |
susceptibility |
ISO |
DNA:SNP: :p.S249P (human) |
RGD |
PMID:16461792 |
RGD:4889535 |
NCBI chr14:43,362,164...43,374,500
Ensembl chr14:43,362,164...43,375,685
|
|
|
G |
Ace |
angiotensin I converting enzyme |
|
ISO |
associated with Cerebrovascular Accident |
RGD |
PMID:14990394 |
RGD:4140926 |
NCBI chr10:90,910,316...90,930,437
Ensembl chr10:90,910,316...90,931,131
|
|
G |
Cxcl1 |
C-X-C motif chemokine ligand 1 |
|
IEP |
|
RGD |
PMID:19515386 |
RGD:4891456 |
NCBI chr14:17,193,364...17,195,143
Ensembl chr14:17,193,365...17,195,215
|
|
G |
Cxcl2 |
C-X-C motif chemokine ligand 2 |
|
IEP |
|
RGD |
PMID:19515386 |
RGD:4891456 |
NCBI chr14:17,181,030...17,183,075
Ensembl chr14:17,181,062...17,183,075
|
|
G |
Edn1 |
endothelin 1 |
|
IEP |
protein:increased secretion:plasma (rat) |
RGD |
PMID:19262391 |
RGD:4145069 |
NCBI chr17:22,454,924...22,460,812
Ensembl chr17:22,454,420...22,460,885
|
|
G |
Il1a |
interleukin 1 alpha |
|
IEP |
protein:increased expression:Bronchoalveolar Lavage Fluid |
RGD |
PMID:18042282 |
RGD:4142854 |
NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822
|
|
G |
Nos2 |
nitric oxide synthase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15607125 |
|
NCBI chr10:64,313,335...64,349,221
Ensembl chr10:63,815,308...63,851,210
|
|
G |
Tnf |
tumor necrosis factor |
|
IEP |
protein:increased expression:Bronchoalveolar Lavage Fluid |
RGD |
PMID:18042282 |
RGD:4142854 |
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,622,011...3,624,629
|
|
|
G |
Pdcd1 |
programmed cell death 1 |
susceptibility |
ISO |
ClinVar Annotator: match by term: AUTOIMMUNE DISEASE WITH SUSCEPTIBILITY TO MYCOBACTERIUM TUBERCULOSIS |
OMIM ClinVar |
PMID:34183838 |
|
NCBI chr 9:94,418,786...94,431,945
Ensembl chr 9:94,418,791...94,431,937
|
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
|
ISO |
ClinVar Annotator: match by term: Mucocutaneous ulceration, chronic | ClinVar Annotator: match by term: RELA-related condition |
OMIM ClinVar |
PMID:25741868 PMID:28492532 PMID:28600438 PMID:29758562 PMID:32969189 PMID:35412596 PMID:36926348 More...
|
|
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Sipa1 |
signal-induced proliferation-associated 1 |
|
ISO |
ClinVar Annotator: match by term: Mucocutaneous ulceration, chronic |
ClinVar |
PMID:25741868 PMID:28492532 PMID:28600438 PMID:36926348 |
|
NCBI chr 1:202,938,532...202,950,672
Ensembl chr 1:202,938,580...202,950,591
|
|
|
G |
Pecam1 |
platelet and endothelial cell adhesion molecule 1 |
|
ISO |
protein:decreased expression:serum (human) |
RGD |
PMID:25539588 |
RGD:11541121 |
NCBI chr10:91,590,521...91,652,279
Ensembl chr10:91,590,521...91,652,116
|
|
|
G |
C3 |
complement C3 |
|
IEP |
associated with Experimental Liver Cirrhosis; protein:decreased expression:serum |
RGD |
PMID:11349015 |
RGD:408395143 |
NCBI chr 9:2,087,437...2,114,366
Ensembl chr 9:2,087,437...2,114,429
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
|
ISO |
associated with Febrile Neutropenia;protein:increased expression:serum (human) |
RGD |
PMID:22584776 |
RGD:11528568 |
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
|
|
G |
Cebpb |
CCAAT/enhancer binding protein beta |
|
ISO |
associated with alcohol use disorder;mRNA:increased expression:bone marrow (mouse) |
RGD |
PMID:28784931 |
RGD:40903040 |
NCBI chr 3:156,398,035...156,399,466
Ensembl chr 3:156,397,052...156,399,473
|
|
G |
Cfh |
complement factor H |
|
ISO |
associated with Meningococcal Infections; |
RGD |
PMID:22104107 |
RGD:7364945 |
NCBI chr13:51,512,376...51,613,829
Ensembl chr13:51,511,828...51,613,838
|
|
G |
Cish |
cytokine inducible SH2-containing protein |
susceptibility |
ISO |
ClinVar Annotator: match by term: Bacteremia, susceptibility to, 2 CTD Direct Evidence: marker/mechanism |
ClinVar CTD OMIM |
PMID:20484391 |
|
NCBI chr 8:107,972,306...107,977,254
Ensembl chr 8:107,972,306...107,977,250
|
|
G |
Cpb2 |
carboxypeptidase B2 |
|
IEP |
protein:decreased activity:plasma |
RGD |
PMID:17911187 |
RGD:2313646 |
NCBI chr15:50,557,722...50,606,569
Ensembl chr15:50,557,717...50,606,556
|
|
G |
Crp |
C-reactive protein |
|
ISO |
protein:increased expression:serum: |
RGD |
PMID:18443549 |
RGD:9491402 |
NCBI chr13:85,135,384...85,175,178
Ensembl chr13:85,124,977...85,175,178
|
|
G |
Csf2 |
colony stimulating factor 2 |
treatment |
ISO |
|
RGD |
PMID:2192004 |
RGD:10449532 |
NCBI chr10:38,386,945...38,388,926
Ensembl chr10:38,386,945...38,389,199
|
|
G |
Fcgr2a |
Fc gamma receptor 2A |
|
ISO |
associated with Pneumonia;DNA:SNP: :p.H131R (rs1801274) (human) |
RGD |
PMID:21317643 |
RGD:5147986 |
NCBI chr13:83,280,782...83,297,535
Ensembl chr13:83,280,784...83,295,967
|
|
G |
Hmgcr |
3-hydroxy-3-methylglutaryl-CoA reductase |
severity |
ISO |
|
RGD |
PMID:11565076 |
RGD:5508478 |
NCBI chr 2:27,997,523...28,018,983
Ensembl chr 2:27,997,525...28,019,703
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
|
ISO |
mRNA:increased expression:lung,thymus,spleen: |
RGD |
PMID:24891762 |
RGD:11354979 |
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
|
|
G |
Il17a |
interleukin 17A |
|
ISO |
associated with Respiratory Distress Syndrome, Adult; protein:increased expression:serum |
RGD |
PMID:21062445 |
RGD:5128683 |
NCBI chr 9:23,144,402...23,147,889
Ensembl chr 9:23,144,402...23,147,889
|
|
G |
Il27 |
interleukin 27 |
|
ISO |
protein:increased expression:blood serum (human) |
RGD |
PMID:26514771 |
RGD:126790515 |
NCBI chr 1:181,173,108...181,178,720
Ensembl chr 1:181,173,372...181,178,582
|
|
G |
Itih4 |
inter-alpha-trypsin inhibitor heavy chain 4 |
|
ISO |
protein:increased expression:liver, serum |
RGD |
PMID:33348064 |
RGD:40907057 |
NCBI chr16:6,080,539...6,095,710
Ensembl chr16:6,080,539...6,095,708
|
|
G |
Mapkapk3 |
MAPK activated protein kinase 3 |
|
ISO |
ClinVar Annotator: match by term: Bacteremia, susceptibility to, 2 |
ClinVar |
PMID:20484391 |
|
NCBI chr 8:107,929,754...107,963,638
Ensembl chr 8:107,929,762...107,963,568
|
|
G |
Mbl2 |
mannose binding lectin 2 |
treatment |
ISO |
associated with Multiple Myeloma:DNA:polymorphism:exon: |
RGD |
PMID:16953214 |
RGD:11530047 |
NCBI chr 1:228,016,439...228,024,736
|
|
G |
Nod2 |
nucleotide-binding oligomerization domain containing 2 |
severity |
ISO |
associated with Staphylococcal Infections; |
RGD |
PMID:24086711 |
RGD:13204726 |
NCBI chr19:18,382,369...18,422,817
Ensembl chr19:18,382,439...18,417,177
|
|
G |
Plat |
plasminogen activator, tissue type |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:1430592 |
|
NCBI chr16:69,240,582...69,265,177
Ensembl chr16:69,240,585...69,268,223
|
|
G |
Plaur |
plasminogen activator, urokinase receptor |
severity |
ISO |
|
RGD |
PMID:21332843 |
RGD:6483799 |
NCBI chr 1:80,053,440...80,068,384
Ensembl chr 1:80,050,324...80,068,595
|
|
G |
Serpinc1 |
serpin family C member 1 |
treatment |
ISO |
|
RGD |
PMID:2679067 |
RGD:11035251 |
NCBI chr13:73,257,208...73,271,476
Ensembl chr13:73,257,179...73,284,293
|
|
G |
Sod2 |
superoxide dismutase 2 |
|
ISO |
mRNA:increased expression:liver: |
RGD |
PMID:24253037 |
RGD:26923958 |
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
|
|
G |
Tirap |
TIR domain containing adaptor protein |
|
ISO |
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Bacteremia, susceptibility to, 1 |
CTD ClinVar OMIM |
PMID:16991088 PMID:17322885 PMID:18305471 PMID:25741868 |
|
NCBI chr 8:33,531,724...33,548,508
Ensembl chr 8:33,531,725...33,547,432
|
|
G |
Tlr4 |
toll-like receptor 4 |
susceptibility |
ISO |
DNA:polymorphisms:cds:p.D299G, T399I (human) |
RGD |
PMID:18180796 |
RGD:4144194 |
NCBI chr 5:80,145,867...80,159,501
Ensembl chr 5:80,145,826...80,159,628
|
|
|
G |
Muc1 |
mucin 1, cell surface associated |
|
ISO |
|
RGD |
PMID:10359313 |
RGD:7349379 |
NCBI chr 2:174,635,989...174,640,738
Ensembl chr 2:174,635,995...174,640,733
|
|
|
G |
Tlr2 |
toll-like receptor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23661603 |
|
NCBI chr 2:169,200,620...169,206,819
Ensembl chr 2:169,197,419...169,206,630
|
|
|
G |
Jak2 |
Janus kinase 2 |
|
ISO |
protein:increased expression:stomach (human) |
RGD |
PMID:24718681 |
RGD:126928128 |
NCBI chr 1:236,408,905...236,468,769
Ensembl chr 1:226,995,334...227,054,189
|
|
G |
Mir146a |
microRNA 146a |
|
ISO |
associated with Helicobacter Infections;miRNA:increased expression:mucosa of stomach (human) |
RGD |
PMID:30535468 |
RGD:126925144 |
NCBI chr10:27,848,516...27,848,610
Ensembl chr10:27,848,516...27,848,610
|
|
G |
Mir375 |
microRNA 375 |
|
ISO |
protein:decreased expression:stomach (human) |
RGD |
PMID:24718681 |
RGD:126928128 |
NCBI chr 9:76,457,911...76,457,985
Ensembl chr 9:76,457,911...76,457,985
|
|
G |
Trem1 |
triggering receptor expressed on myeloid cells 1 |
|
ISO |
mRNA,protein:increased expression:gastric epithelium |
RGD |
PMID:18321350 |
RGD:126928123 |
NCBI chr 9:12,763,819...12,779,285
Ensembl chr 9:12,763,819...12,779,203
|
|
|
G |
Casp3 |
caspase 3 |
|
ISO |
associated with Diabetes Mellitus, Non-Insulin-Dependent |
RGD |
PMID:16443785 |
RGD:2311430 |
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp8 |
caspase 8 |
|
ISO |
associated with Diabetes Mellitus, Non-Insulin-Dependent |
RGD |
PMID:16443785 |
RGD:2311430 |
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
|
|
G |
Casp9 |
caspase 9 |
|
ISO |
associated with Diabetes Mellitus, Non-Insulin-Dependent |
RGD |
PMID:16443785 |
RGD:2311430 |
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Crp |
C-reactive protein |
|
ISO |
|
RGD |
PMID:23937512 |
RGD:9495911 |
NCBI chr13:85,135,384...85,175,178
Ensembl chr13:85,124,977...85,175,178
|
|
G |
Dock8 |
dedicator of cytokinesis 8 |
susceptibility |
ISO |
DNA:mutations: : |
RGD |
PMID:25724123 |
RGD:40886274 |
NCBI chr 1:222,649,309...222,842,474
Ensembl chr 1:222,649,309...222,842,474
|
|
G |
Il10 |
interleukin 10 |
|
ISO |
associated with Otitis Media |
RGD |
PMID:22668804 |
RGD:7364828 |
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
|
|
G |
Il2 |
interleukin 2 |
|
ISO |
associated with Diabetes Mellitus, Type 2;protein:decreased expression:blood |
RGD |
PMID:21574159 |
RGD:5147907 |
NCBI chr 2:121,932,968...121,937,672
Ensembl chr 2:120,004,862...120,009,566
|
|
G |
Mbl2 |
mannose binding lectin 2 |
susceptibility |
ISO |
associated with Precursor B-Cell Lymphoblastic Leukemia-Lymphoma;DNA:polymorphism:exon: |
RGD |
PMID:24453114 |
RGD:11530056 |
NCBI chr 1:228,016,439...228,024,736
|
|
G |
Nod2 |
nucleotide-binding oligomerization domain containing 2 |
|
ISO |
associated with Virus Diseases |
RGD |
PMID:21669398 |
RGD:5508748 |
NCBI chr19:18,382,369...18,422,817
Ensembl chr19:18,382,439...18,417,177
|
|
G |
RT1-Bb |
RT1 class II, locus Bb |
onset |
ISO |
associated with Cystic Fibrosis;DNA:polymorphism (human) |
RGD |
PMID:16987934 |
RGD:5147635 |
NCBI chr20:4,596,558...4,602,201
Ensembl chr20:4,596,559...4,607,597
|
|
G |
RT1-Db1 |
RT1 class II, locus Db1 |
onset |
ISO |
associated with Cystic Fibrosis;DNA:polymorphism (human) |
RGD |
PMID:16987934 |
RGD:5147635 |
NCBI chr20:4,548,664...4,558,237
Ensembl chr20:4,548,666...4,558,258
|
|
G |
Sdc4 |
syndecan 4 |
|
IMP |
|
RGD |
PMID:15001228 |
RGD:2312325 |
NCBI chr 3:153,154,888...153,173,576
Ensembl chr 3:153,154,896...153,173,580
|
|
G |
Tbce |
tubulin folding cofactor E |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12389028 |
|
NCBI chr17:51,290,143...51,336,090
Ensembl chr17:51,290,202...51,336,089
|
|
|
G |
Il1r1 |
interleukin 1 receptor type 1 |
|
ISO |
associated with Serratia Infections; |
RGD |
PMID:23033384 |
RGD:8662876 |
NCBI chr 9:42,504,917...42,580,958
Ensembl chr 9:42,504,735...42,579,937
|
|
G |
Ly96 |
lymphocyte antigen 96 |
|
ISO |
associated with Serratia Infections; |
RGD |
PMID:23033384 |
RGD:8662876 |
NCBI chr 5:2,582,233...2,612,357
Ensembl chr 5:2,582,254...2,612,386
|
|
G |
Myd88 |
MYD88, innate immune signal transduction adaptor |
|
ISO |
associated with Staphylococcal Infections; associated with Serratia Infections; |
RGD |
PMID:16926427 PMID:23033384 |
RGD:8552819, RGD:8662876 |
NCBI chr 8:119,074,439...119,078,508
Ensembl chr 8:119,074,437...119,079,415
|
|
G |
Tlr2 |
toll-like receptor 2 |
|
ISO |
associated with Staphylococcal Infections; associated with Pneumococcal Infections; |
RGD |
PMID:16926427 PMID:23841825 |
RGD:8552819, RGD:8552886 |
NCBI chr 2:169,200,620...169,206,819
Ensembl chr 2:169,197,419...169,206,630
|
|
G |
Tlr4 |
toll-like receptor 4 |
|
ISO |
associated with Pneumococcal Infections; associated with Serratia Infections; |
RGD |
PMID:23841825 PMID:23033384 |
RGD:8552886, RGD:8662876 |
NCBI chr 5:80,145,867...80,159,501
Ensembl chr 5:80,145,826...80,159,628
|
|
G |
Tlr5 |
toll-like receptor 5 |
|
ISO |
associated with Serratia Infections; |
RGD |
PMID:23033384 |
RGD:8662876 |
NCBI chr13:94,634,778...94,658,992
Ensembl chr13:94,634,801...94,657,738
|
|
|
G |
Marco |
macrophage receptor with collagenous structure |
disease_progression |
ISO |
association with Cryptococcal neoformans infection. |
RGD |
PMID:28298522 |
RGD:41412191 |
NCBI chr13:31,616,278...31,648,521
Ensembl chr13:31,616,278...31,648,521
|
|
|
G |
Ache |
acetylcholinesterase |
|
ISO |
|
RGD |
PMID:21303225 |
RGD:5688130 |
NCBI chr12:19,406,133...19,413,713
Ensembl chr12:19,407,360...19,413,651
|
|
G |
Bche |
butyrylcholinesterase |
|
ISO |
protein:increased expression:blood |
RGD |
PMID:21303225 |
RGD:5688130 |
NCBI chr 2:158,308,674...158,401,148
Ensembl chr 2:158,307,584...158,401,148
|
|
G |
Bdnf |
brain-derived neurotrophic factor |
|
ISO IEP |
mRNA, protein:increased expression:hippocampus mRNA:decreased expression:hippocampus,cerebral cortex: |
RGD |
PMID:16141791 PMID:22683802 |
RGD:5684920, RGD:8655554 |
NCBI chr 3:116,619,633...116,670,212
Ensembl chr 3:96,165,042...96,215,615
|
|
G |
Cd46 |
CD46 molecule |
|
ISO |
|
RGD |
PMID:16948860 |
RGD:6483465 |
NCBI chr13:106,575,586...106,606,325
Ensembl chr13:106,574,858...106,660,445
|
|
G |
Chi3l1 |
chitinase 3 like 1 |
severity |
ISO |
protein:increased secretion:cerebrospinal fluid (human) |
RGD |
PMID:11986266 |
RGD:4892662 |
NCBI chr13:45,641,802...45,649,787
Ensembl chr13:45,641,802...45,649,787
|
|
G |
Crp |
C-reactive protein |
|
ISO |
protein:increased expression:serum: |
RGD |
PMID:6122844 |
RGD:9491388 |
NCBI chr13:85,135,384...85,175,178
Ensembl chr13:85,124,977...85,175,178
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
|
ISO |
|
RGD |
PMID:10430840 |
RGD:8547971 |
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
|
|
G |
Ngf |
nerve growth factor |
|
IEP |
mRNA:decreased expression:hippocampus: |
RGD |
PMID:22683802 |
RGD:8655554 |
NCBI chr 2:189,901,058...189,954,452
Ensembl chr 2:189,901,058...189,954,452
|
|
G |
Ntrk2 |
neurotrophic receptor tyrosine kinase 2 |
|
ISO |
mRNA, protein:increased expression:hippocampus |
RGD |
PMID:16141791 |
RGD:5684920 |
NCBI chr17:5,558,992...5,870,299
Ensembl chr17:5,559,043...5,869,136
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
susceptibility |
ISO |
DNA:snp:cds:p.V762A rs1136410 (human) |
RGD |
PMID:21651918 |
RGD:5683901 |
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
|
|
G |
S100b |
S100 calcium binding protein B |
|
ISO |
protein:increased expression:cerebrospinal fluid |
RGD |
PMID:15105355 |
RGD:5508818 |
NCBI chr20:12,372,866...12,381,619
Ensembl chr20:12,372,881...12,394,743
|
|
G |
Trem1 |
triggering receptor expressed on myeloid cells 1 |
disease_progression |
ISO |
|
RGD |
PMID:16786330 |
RGD:126928126 |
NCBI chr 9:12,763,819...12,779,285
Ensembl chr 9:12,763,819...12,779,203
|
|
|
G |
Abcc1 |
ATP binding cassette subfamily C member 1 |
|
ISO |
|
RGD |
PMID:11238654 |
RGD:5128828 |
NCBI chr10:528,961...655,179
Ensembl chr10:531,812...655,114
|
|
G |
Ace2 |
angiotensin converting enzyme 2 |
|
ISO |
associated with Pseudomonas Infections;mRNA, protein:altered expression, altered activity:lung (mouse) |
RGD |
PMID:31645418 |
RGD:40818279 |
NCBI chr X:30,293,597...30,340,961
Ensembl chr X:30,293,589...30,340,977
|
|
G |
Ager |
advanced glycosylation end product-specific receptor |
severity |
ISO |
|
RGD |
PMID:21629785 |
RGD:6767559 |
NCBI chr20:4,148,150...4,151,361
Ensembl chr20:4,147,890...4,151,078
|
|
G |
C3 |
complement C3 |
|
ISO |
|
RGD |
PMID:16014897 |
RGD:5129508 |
NCBI chr 9:2,087,437...2,114,366
Ensembl chr 9:2,087,437...2,114,429
|
|
G |
C3ar1 |
complement C3a receptor 1 |
|
ISO |
|
RGD |
PMID:16461429 |
RGD:5129690 |
NCBI chr 4:156,074,747...156,084,680
Ensembl chr 4:156,075,389...156,084,701
|
|
G |
C5 |
complement C5 |
|
ISO |
|
RGD |
PMID:17975174 |
RGD:5129707 |
NCBI chr 3:18,270,696...18,361,994
Ensembl chr 3:18,270,696...18,361,994
|
|
G |
Cat |
catalase |
|
IDA |
protein:decreased expression:lung, plasma |
RGD |
PMID:19842849 |
RGD:5130748 |
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Ccl19 |
C-C motif chemokine ligand 19 |
|
ISO |
mRNA, protein:increased expression:lung |
RGD |
PMID:20176793 |
RGD:5130918 |
NCBI chr 5:56,963,364...56,965,308
Ensembl chr 5:56,963,364...56,965,308
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
|
ISO |
|
RGD |
PMID:20042590 |
RGD:4891443 |
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
|
|
G |
Ccl4 |
C-C motif chemokine ligand 4 |
|
ISO |
|
RGD |
PMID:20483921 |
RGD:5130905 |
NCBI chr10:68,466,394...68,468,229
Ensembl chr10:68,452,052...68,468,231
|
|
G |
Ccr2 |
C-C motif chemokine receptor 2 |
|
ISO |
|
RGD |
PMID:20042590 |
RGD:4891443 |
NCBI chr 8:123,734,465...123,742,483
Ensembl chr 8:123,734,430...123,742,100
|
|
G |
Ccr7 |
C-C motif chemokine receptor 7 |
|
ISO |
|
RGD |
PMID:20176793 |
RGD:5130918 |
NCBI chr10:84,098,193...84,108,309
Ensembl chr10:84,097,381...84,108,309
|
|
G |
Cd14 |
CD14 molecule |
|
ISO |
|
RGD |
PMID:16210672 |
RGD:4144197 |
NCBI chr18:28,335,522...28,337,383
Ensembl chr18:28,335,340...28,337,261
|
|
G |
Cd40 |
CD40 molecule |
|
ISO |
|
RGD |
PMID:20102413 |
RGD:5132268 |
NCBI chr 3:153,790,372...153,805,279
Ensembl chr 3:153,790,449...153,805,534
|
|
G |
Cd80 |
Cd80 molecule |
|
ISO |
|
RGD |
PMID:20949109 |
RGD:4892562 |
NCBI chr11:62,254,543...62,293,414
Ensembl chr11:62,254,624...62,292,030
|
|
G |
Chuk |
component of inhibitor of nuclear factor kappa B kinase complex |
|
ISO |
|
RGD |
PMID:18643924 |
RGD:5133701 |
NCBI chr 1:242,959,539...242,995,066
Ensembl chr 1:242,959,760...242,995,065
|
|
G |
Csf3 |
colony stimulating factor 3 |
disease_progression treatment |
ISO |
associated with Peritonitis; |
RGD |
PMID:21373266 PMID:12352049 |
RGD:5133733, RGD:11039437 |
NCBI chr10:83,660,787...83,664,569
Ensembl chr10:83,661,207...83,663,603
|
|
G |
Csf3r |
colony stimulating factor 3 receptor |
disease_progression |
ISO |
|
RGD |
PMID:17185469 |
RGD:5133739 |
NCBI chr 5:138,298,605...138,318,224
Ensembl chr 5:138,301,506...138,317,881
|
|
G |
Cxcl1 |
C-X-C motif chemokine ligand 1 |
|
ISO IEP |
|
RGD |
PMID:21723409 PMID:11052817 |
RGD:5135062, RGD:5135234 |
NCBI chr14:17,193,364...17,195,143
Ensembl chr14:17,193,365...17,195,215
|
|
G |
Cxcl10 |
C-X-C motif chemokine ligand 10 |
severity |
ISO |
|
RGD |
PMID:16299319 PMID:15618188 |
RGD:5135458, RGD:5135459 |
NCBI chr14:15,704,772...15,706,969
Ensembl chr14:15,704,758...15,706,975
|
|
G |
Cxcl11 |
C-X-C motif chemokine ligand 11 |
|
ISO |
|
RGD |
PMID:15618188 |
RGD:5135459 |
NCBI chr14:15,689,432...15,692,207
Ensembl chr14:15,689,424...15,692,271
|
|
G |
Cxcl2 |
C-X-C motif chemokine ligand 2 |
severity |
ISO IEP |
|
RGD |
PMID:19239431 PMID:11052817 PMID:21723409 |
RGD:5135065, RGD:5135234, RGD:5135062 |
NCBI chr14:17,181,030...17,183,075
Ensembl chr14:17,181,062...17,183,075
|
|
G |
Cxcl3 |
C-X-C motif chemokine ligand 3 |
|
IEP |
|
RGD |
PMID:11052817 |
RGD:5135234 |
NCBI chr14:17,287,727...17,289,451
Ensembl chr14:17,270,146...17,289,511
|
|
G |
Cxcl6 |
C-X-C motif chemokine ligand 6 |
|
ISO |
|
RGD |
PMID:19846873 |
RGD:4145490 |
NCBI chr14:17,310,790...17,312,250
Ensembl chr14:17,310,426...17,313,093
|
|
G |
Cxcl9 |
C-X-C motif chemokine ligand 9 |
|
ISO |
|
RGD |
PMID:15618188 |
RGD:5135459 |
NCBI chr14:15,722,868...15,727,779
Ensembl chr14:15,722,908...15,728,435
|
|
G |
Cxcr3 |
C-X-C motif chemokine receptor 3 |
|
ISO |
|
RGD |
PMID:15618188 |
RGD:5135459 |
NCBI chr X:66,844,318...66,846,969
Ensembl chr X:66,844,318...66,846,969
|
|
G |
Cyp2j4 |
cytochrome P450, family 2, subfamily j, polypeptide 4 |
|
IEP |
protein:decreased expression:lung |
RGD |
PMID:14766666 |
RGD:1625385 |
NCBI chr 5:111,179,981...111,207,490
Ensembl chr 5:111,178,703...111,244,794
|
|
G |
Defb4 |
defensin beta 4 |
|
ISO |
protein:increased expression:plasma |
RGD |
PMID:10213993 |
RGD:4892266 |
NCBI chr16:70,650,472...70,653,665
Ensembl chr16:70,650,472...70,653,665
|
|
G |
Defb5 |
defensin beta 5 |
|
ISO |
protein:increased expression:plasma |
RGD |
PMID:10213993 |
RGD:4892266 |
NCBI chr16:70,612,985...70,615,389
Ensembl chr16:70,613,146...70,615,467
|
|
G |
F2 |
coagulation factor II, thrombin |
|
IEP |
protein:increased expression:lung |
RGD |
PMID:21897338 |
RGD:6893486 |
NCBI chr 3:77,596,196...77,609,486
Ensembl chr 3:77,596,198...77,609,486
|
|
G |
Fcgr2a |
Fc gamma receptor 2A |
|
ISO |
|
RGD |
PMID:17975174 |
RGD:5129707 |
NCBI chr13:83,280,782...83,297,535
Ensembl chr13:83,280,784...83,295,967
|
|
G |
Foxp3 |
forkhead box P3 |
severity |
ISO |
|
RGD |
PMID:25398094 |
RGD:38501102 |
NCBI chr X:14,908,494...14,924,994
Ensembl chr X:14,908,494...14,923,838
|
|
G |
Gp1ba |
glycoprotein Ib platelet subunit alpha |
exacerbates |
ISO |
associated with Escherichia Coli Infections |
RGD |
PMID:27845343 |
RGD:42722624 |
NCBI chr10:55,352,938...55,355,804
Ensembl chr10:55,352,899...55,356,774
|
|
G |
Grk2 |
G protein-coupled receptor kinase 2 |
|
ISO |
mRNA:decreased expression:polymorphonuclear leukocyte |
RGD |
PMID:24465168 |
RGD:126848796 |
NCBI chr 1:201,580,823...201,601,580
Ensembl chr 1:201,581,480...201,601,582
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
|
ISO |
protein:increased expression:lung (mouse) |
RGD |
PMID:19846873 |
RGD:4145490 |
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
|
|
G |
Ifnar1 |
interferon alpha and beta receptor subunit 1 |
severity |
ISO |
|
RGD |
PMID:19487810 PMID:19487810 |
RGD:5490274, RGD:5490274 |
NCBI chr11:30,725,774...30,752,227
Ensembl chr11:30,725,790...30,749,979
|
|
G |
Ifng |
interferon gamma |
severity |
ISO |
|
RGD |
PMID:25398094 |
RGD:38501102 |
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
|
|
G |
Il10 |
interleukin 10 |
severity |
ISO |
|
RGD |
PMID:25398094 |
RGD:38501102 |
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
|
|
G |
Il15 |
interleukin 15 |
|
ISO |
|
RGD |
PMID:17911627 |
RGD:5000754 |
NCBI chr19:25,640,025...25,706,818
Ensembl chr19:25,640,251...25,706,820
|
|
G |
Il17a |
interleukin 17A |
severity |
ISO |
|
RGD |
PMID:18802100 PMID:25398094 |
RGD:4889153, RGD:38501102 |
NCBI chr 9:23,144,402...23,147,889
Ensembl chr 9:23,144,402...23,147,889
|
|
G |
Il18 |
interleukin 18 |
|
ISO |
|
RGD |
PMID:17664259 |
RGD:4889913 |
NCBI chr 8:50,904,630...50,932,887
Ensembl chr 8:50,906,960...50,932,887
|
|
G |
Il1b |
interleukin 1 beta |
severity treatment |
ISO |
associated with Agranulocytosis |
RGD |
PMID:18596024 PMID:25398094 PMID:7546648 |
RGD:4143205, RGD:38501102, RGD:10755357 |
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il1rl1 |
interleukin 1 receptor-like 1 |
treatment |
ISO IEP |
associated with Sepsis associated with Acinetobacter infectious disease |
RGD |
PMID:20959556 PMID:29508184 |
RGD:5144223, RGD:40818077 |
NCBI chr 9:42,661,694...42,727,266
Ensembl chr 9:42,697,192...42,727,256
|
|
G |
Il1rn |
interleukin 1 receptor antagonist |
|
ISO |
|
RGD |
PMID:18596024 PMID:18322242 |
RGD:4143205, RGD:4143206 |
NCBI chr 3:7,111,567...7,127,451
Ensembl chr 3:7,111,550...7,127,445
|
|
G |
Il22 |
interleukin 22 |
|
ISO |
|
RGD |
PMID:21178015 |
RGD:5147404 |
NCBI chr 7:53,801,206...53,805,673
Ensembl chr 7:53,801,206...53,806,186
|
|
G |
Il6 |
interleukin 6 |
severity |
ISO |
|
RGD |
PMID:25398094 |
RGD:38501102 |
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Irak3 |
interleukin-1 receptor-associated kinase 3 |
|
ISO |
|
RGD |
PMID:28120642 PMID:20439918 |
RGD:34888234, RGD:36049799 |
NCBI chr 7:55,653,949...55,714,371
Ensembl chr 7:55,653,962...55,713,121
|
|
G |
Irf1 |
interferon regulatory factor 1 |
|
ISO |
|
RGD |
PMID:11854220 |
RGD:5128725 |
NCBI chr10:37,917,155...37,924,166
Ensembl chr10:37,916,670...37,924,166
|
|
G |
Irf3 |
interferon regulatory factor 3 |
|
ISO |
|
RGD |
PMID:20720199 |
RGD:4891951 |
NCBI chr 1:95,479,966...95,484,926
Ensembl chr 1:95,479,821...95,484,935
|
|
G |
Itgb3 |
integrin subunit beta 3 |
|
IEP |
protein:increased expression:lung, neutrophil |
RGD |
PMID:15114484 |
RGD:4993468 |
NCBI chr10:89,509,917...89,564,679
Ensembl chr10:89,509,989...89,564,679
|
|
G |
Lep |
leptin |
|
ISO |
|
RGD |
PMID:11937559 |
RGD:5128871 |
NCBI chr 4:57,661,127...57,675,262
Ensembl chr 4:57,661,131...57,675,262
|
|
G |
Mapk8 |
mitogen-activated protein kinase 8 |
severity |
ISO |
associated with Escherichia Coli Infections |
RGD |
PMID:22514650 |
RGD:150340681 |
NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981
|
|
G |
Mbl2 |
mannose binding lectin 2 |
|
ISO |
Legionella Pneumonia; DNA:mutations:5' utr, exon:multiple (human) |
RGD |
PMID:18641104 |
RGD:4889477 |
NCBI chr 1:228,016,439...228,024,736
|
|
G |
Mc1r |
melanocortin 1 receptor |
|
ISO |
|
RGD |
PMID:18304533 |
RGD:5687324 |
NCBI chr19:51,452,448...51,455,375
Ensembl chr19:51,453,239...51,454,192
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
|
ISO |
protein:increased expression:bronchoalveolar lavage fluid |
RGD |
PMID:17202364 PMID:19535150 |
RGD:5130727, RGD:5129533 |
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
|
|
G |
Mpo |
myeloperoxidase |
|
ISO |
protein:increased activity:bronchoalveolar lavage Fluid: |
RGD |
PMID:11269653 |
RGD:5130992 |
NCBI chr10:72,594,883...72,608,862
Ensembl chr10:72,594,661...72,604,819
|
|
G |
Nod1 |
nucleotide-binding oligomerization domain containing 1 |
|
ISO |
|
RGD |
PMID:19360122 |
RGD:5131449 |
NCBI chr 4:84,060,871...84,111,668
Ensembl chr 4:84,060,880...84,111,404
|
|
G |
Nod2 |
nucleotide-binding oligomerization domain containing 2 |
|
ISO |
|
RGD |
PMID:19360122 |
RGD:5131449 |
NCBI chr19:18,382,369...18,422,817
Ensembl chr19:18,382,439...18,417,177
|
|
G |
Pdpn |
podoplanin |
|
IEP |
protein:increased expression:lung |
RGD |
PMID:7864138 |
RGD:2292375 |
NCBI chr 5:155,601,691...155,635,656
Ensembl chr 5:155,601,691...155,635,656
|
|
G |
Pecam1 |
platelet and endothelial cell adhesion molecule 1 |
|
IEP |
protein:decreased expression:lung |
RGD |
PMID:12524254 |
RGD:724645 |
NCBI chr10:91,590,521...91,652,279
Ensembl chr10:91,590,521...91,652,116
|
|
G |
Pgf |
placental growth factor |
|
ISO |
protein:increased expression:plasma |
RGD |
PMID:16702604 |
RGD:6483601 |
NCBI chr 6:104,816,102...104,826,685
Ensembl chr 6:104,816,104...104,826,685
|
|
G |
Pten |
phosphatase and tensin homolog |
ameliorates |
ISO |
myeloid knockout |
RGD |
PMID:21527775 |
RGD:127285594 |
NCBI chr 1:230,630,443...230,697,070
Ensembl chr 1:230,630,338...230,696,838
|
|
G |
Ripk3 |
receptor-interacting serine-threonine kinase 3 |
ameliorates |
ISO |
|
RGD |
PMID:28387756 |
RGD:127229944 |
NCBI chr15:29,283,153...29,292,107
Ensembl chr15:29,283,145...29,292,121
|
|
G |
Rorc |
RAR-related orphan receptor C |
severity |
ISO |
|
RGD |
PMID:25398094 |
RGD:38501102 |
NCBI chr 2:182,009,707...182,034,910
Ensembl chr 2:182,009,286...182,034,907
|
|
G |
Serpine1 |
serpin family E member 1 |
severity |
ISO |
|
RGD |
PMID:17032919 |
RGD:4144840 |
NCBI chr12:19,601,272...19,611,657
Ensembl chr12:19,601,272...19,611,657
|
|
G |
Sftpa1 |
surfactant protein A1 |
|
IEP |
protein:increased expression:lung |
RGD |
PMID:12169586 |
RGD:4143464 |
NCBI chr16:17,008,180...17,011,686
Ensembl chr16:17,008,180...17,011,685
|
|
G |
Sftpb |
surfactant protein B |
|
ISO IEP |
associated with Cystic Fibrosis;protein:increased expression:lung |
RGD |
PMID:15271694 PMID:12169586 |
RGD:4143403, RGD:4143464 |
NCBI chr 4:104,359,303...104,368,439
Ensembl chr 4:104,359,396...104,368,436
|
|
G |
Sftpc |
surfactant protein C |
|
ISO IEP |
|
RGD |
PMID:18566429 PMID:12169586 |
RGD:4144114, RGD:4143464 |
NCBI chr15:45,596,565...45,599,615
Ensembl chr15:45,596,574...45,610,777
|
|
G |
Sftpd |
surfactant protein D |
|
ISO IEP |
associated with Cystic Fibrosis;protein:decreased expression:lung protein:increased expression:lung |
RGD |
PMID:15271694 PMID:12169586 |
RGD:4143403, RGD:4143464 |
NCBI chr16:17,046,491...17,058,968
Ensembl chr16:17,046,483...17,059,927
|
|
G |
Stat3 |
signal transducer and activator of transcription 3 |
|
ISO |
|
RGD |
PMID:18192501 |
RGD:6892945 |
NCBI chr10:86,311,528...86,363,513
Ensembl chr10:85,811,218...85,863,057
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
severity |
ISO |
|
RGD |
PMID:25398094 |
RGD:38501102 |
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
|
|
G |
Tlr2 |
toll-like receptor 2 |
|
ISO IDA |
|
RGD |
PMID:18768871 PMID:19844782 |
RGD:4145337, RGD:4889533 |
NCBI chr 2:169,200,620...169,206,819
Ensembl chr 2:169,197,419...169,206,630
|
|
G |
Tlr4 |
toll-like receptor 4 |
|
ISO |
|
RGD |
PMID:20650991 PMID:16210672 |
RGD:4144172, RGD:4144197 |
NCBI chr 5:80,145,867...80,159,501
Ensembl chr 5:80,145,826...80,159,628
|
|
G |
Tlr5 |
toll-like receptor 5 |
|
ISO |
|
RGD |
PMID:19801452 |
RGD:5129503 |
NCBI chr13:94,634,778...94,658,992
Ensembl chr13:94,634,801...94,657,738
|
|
G |
Tlr6 |
toll-like receptor 6 |
|
IDA |
|
RGD |
PMID:19844782 |
RGD:4889533 |
NCBI chr14:43,362,164...43,374,500
Ensembl chr14:43,362,164...43,375,685
|
|
G |
Tlr9 |
toll-like receptor 9 |
|
ISO |
|
RGD |
PMID:20360853 |
RGD:5130719 |
NCBI chr 8:106,864,680...106,868,796
Ensembl chr 8:106,864,680...106,868,796
|
|
G |
Tnf |
tumor necrosis factor |
disease_progression treatment severity |
ISO |
associated with Agranulocytosis |
RGD |
PMID:10650487 PMID:7546648 PMID:9310939 PMID:12958055 |
RGD:4143476, RGD:10755357, RGD:10450564, RGD:10449451 |
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tnfrsf1a |
TNF receptor superfamily member 1A |
|
ISO |
protein:increased expression:serum (mouse) |
RGD |
PMID:19842848 |
RGD:5131429 |
NCBI chr 4:158,150,815...158,163,592
Ensembl chr 4:158,150,820...158,163,591
|
|
G |
Tnfrsf1b |
TNF receptor superfamily member 1B |
|
ISO |
protein:increased expression:serum (mouse) |
RGD |
PMID:19842848 |
RGD:5131429 |
NCBI chr 5:157,070,642...157,104,216
Ensembl chr 5:157,070,642...157,104,206
|
|
G |
Trem1 |
triggering receptor expressed on myeloid cells 1 |
severity ameliorates |
ISO IDA |
|
RGD |
PMID:24465168 PMID:16960786 PMID:22996209 |
RGD:126848796, RGD:127229902, RGD:126925987 |
NCBI chr 9:12,763,819...12,779,285
Ensembl chr 9:12,763,819...12,779,203
|
|
G |
Zc3h12a |
zinc finger CCCH type containing 12A |
|
ISO |
associated with Pseudomonas Infections |
RGD |
PMID:29695841 |
RGD:39938967 |
NCBI chr 5:137,376,562...137,385,351
Ensembl chr 5:137,376,564...137,385,351
|
|
|
G |
Trem1 |
triggering receptor expressed on myeloid cells 1 |
treatment ameliorates exacerbates |
ISO IDA |
associated with bacterial pneumonia |
RGD |
PMID:21507332 PMID:16960786 PMID:17230441 |
RGD:126925982, RGD:127229902, RGD:126928125 |
NCBI chr 9:12,763,819...12,779,285
Ensembl chr 9:12,763,819...12,779,203
|
|
|
G |
Mbl2 |
mannose binding lectin 2 |
|
ISO |
DNA:SNP:cds: |
RGD |
PMID:17470593 |
RGD:8693700 |
NCBI chr 1:228,016,439...228,024,736
|
|
|
G |
Clec4m |
C-type lectin domain family 4 member M |
|
ISO |
associated with Escherichia Coli Infections |
RGD |
PMID:31998663 |
RGD:41410804 |
NCBI chr12:1,915,902...1,924,529
Ensembl chr12:1,915,919...1,924,539
|
|
|
G |
Cxcl2 |
C-X-C motif chemokine ligand 2 |
|
ISO |
associated with Influenza |
RGD |
PMID:20065113 |
RGD:5134984 |
NCBI chr14:17,181,030...17,183,075
Ensembl chr14:17,181,062...17,183,075
|
|
|
G |
Aldoc |
aldolase, fructose-bisphosphate C |
|
IEP |
mRNA, protein:decreased expression:cerebellum, Purkinje cell |
RGD |
PMID:17182680 |
RGD:2301132 |
NCBI chr10:63,217,477...63,221,066
Ensembl chr10:63,217,451...63,221,066
|
|
G |
Atf4 |
activating transcription factor 4 |
|
IEP |
protein:increased expression:cerebellum |
RGD |
PMID:16912310 |
RGD:32733622 |
NCBI chr 7:111,804,135...111,806,457
Ensembl chr 7:111,804,183...111,806,446
|
|
G |
Atf6 |
activating transcription factor 6 |
|
IEP |
protein:increased expression:cerebellum, hippocampus |
RGD |
PMID:16912310 |
RGD:32733622 |
NCBI chr13:82,927,579...83,106,381
Ensembl chr13:82,930,034...83,107,177
|
|
G |
Bdnf |
brain-derived neurotrophic factor |
|
IEP |
mRNA:decreased expression:hippocampus |
RGD |
PMID:11175319 |
RGD:2325644 |
NCBI chr 3:116,619,633...116,670,212
Ensembl chr 3:96,165,042...96,215,615
|
|
G |
Cd44 |
CD44 molecule |
|
IEP |
|
RGD |
PMID:16612977 |
RGD:2289373 |
NCBI chr 3:89,155,850...89,244,615
Ensembl chr 3:89,157,058...89,244,620
|
|
G |
Cx3cl1 |
C-X3-C motif chemokine ligand 1 |
|
IEP |
|
RGD |
PMID:12053272 |
RGD:4891998 |
NCBI chr19:10,227,337...10,237,826
Ensembl chr19:10,227,340...10,236,833
|
|
G |
Cx3cr1 |
C-X3-C motif chemokine receptor 1 |
|
IEP |
mRNA:increased expression:brain |
RGD |
PMID:12053272 |
RGD:4891998 |
NCBI chr 8:119,785,726...119,799,431
Ensembl chr 8:119,782,595...119,800,014
|
|
G |
Ddit3 |
DNA-damage inducible transcript 3 |
|
IEP |
mRNA,protein:increased expression:cerebellum, hippocampus |
RGD |
PMID:16912310 |
RGD:32733622 |
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
|
|
G |
Eif2a |
eukaryotic translation initiation factor 2A |
|
IEP |
protein:increased expression:cerebellum,hippocampus |
RGD |
PMID:16912310 |
RGD:32733622 |
NCBI chr 2:142,761,303...142,794,767
Ensembl chr 2:142,761,416...142,795,068
|
|
G |
Gja1 |
gap junction protein, alpha 1 |
|
IEP |
|
RGD |
PMID:18538309 |
RGD:7364785 |
NCBI chr20:35,756,007...35,768,481
Ensembl chr20:35,755,991...35,768,582
|
|
G |
Gjb6 |
gap junction protein, beta 6 |
|
IEP |
|
RGD |
PMID:18538309 |
RGD:7364785 |
NCBI chr15:31,284,561...31,294,552
Ensembl chr15:31,284,419...31,294,582
|
|
G |
Igf1 |
insulin-like growth factor 1 |
|
IEP |
mRNA:increased expression:hippocampus |
RGD |
PMID:11175319 |
RGD:2325644 |
NCBI chr 7:22,282,895...22,361,972
Ensembl chr 7:22,282,930...22,359,296
|
|
G |
Il16 |
interleukin 16 |
|
IEP |
protein:increased expression:brain |
RGD |
PMID:14698845 |
RGD:1354526 |
NCBI chr 1:137,617,702...137,718,022
Ensembl chr 1:137,617,944...137,718,130
|
|
G |
Mif |
macrophage migration inhibitory factor |
|
IEP |
protein:increased expression:astrocyte |
RGD |
PMID:11870869 |
RGD:1642006 |
NCBI chr20:12,790,919...12,791,784
Ensembl chr20:12,790,902...12,799,504 Ensembl chr 4:12,790,902...12,799,504
|
|
G |
Mt3 |
metallothionein 3 |
|
IEP |
|
RGD |
PMID:16612977 |
RGD:2289373 |
NCBI chr19:10,848,754...10,850,158
Ensembl chr19:10,848,755...10,850,158
|
|
G |
Ngf |
nerve growth factor |
|
IEP |
mRNA:decreased expression:hippocampus |
RGD |
PMID:11175319 |
RGD:2325644 |
NCBI chr 2:189,901,058...189,954,452
Ensembl chr 2:189,901,058...189,954,452
|
|
G |
Ntf3 |
neurotrophin 3 |
|
IEP |
mRNA:decreased expression:hippocampus |
RGD |
PMID:11175319 |
RGD:2325644 |
NCBI chr 4:158,914,984...158,984,453
Ensembl chr 4:158,914,957...158,984,596
|
|
G |
Ntrk2 |
neurotrophic receptor tyrosine kinase 2 |
|
IEP |
mRNA:decreased expression:cerebellum,hippocampus |
RGD |
PMID:11175319 |
RGD:2325644 |
NCBI chr17:5,558,992...5,870,299
Ensembl chr17:5,559,043...5,869,136
|
|
G |
Ntrk3 |
neurotrophic receptor tyrosine kinase 3 |
|
IEP |
mRNA:decreased expression:cerebellum,hippocampus |
RGD |
PMID:11175319 |
RGD:2325644 |
NCBI chr 1:132,116,472...132,503,849
Ensembl chr 1:132,132,849...132,503,286
|
|
G |
Parg |
poly (ADP-ribose) glycohydrolase |
|
IEP |
mRNA:decreased expression:hippocampus |
RGD |
PMID:18057239 |
RGD:2316738 |
NCBI chr16:7,436,429...7,544,276
Ensembl chr16:7,436,476...7,544,273
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
|
IEP |
mRNA,protein:increased expression,increased activity:neuron, glial cell: |
RGD |
PMID:18057239 |
RGD:2316738 |
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
|
|
G |
S100b |
S100 calcium binding protein B |
|
IEP |
protein:decreased expression:cerebellum, cerebral cortex |
RGD |
PMID:17376896 |
RGD:5508841 |
NCBI chr20:12,372,866...12,381,619
Ensembl chr20:12,372,881...12,394,743
|
|
G |
Slc6a4 |
solute carrier family 6 member 4 |
|
IEP |
protein:increased expression:brain (rat) |
RGD |
PMID:12106671 |
RGD:38549588 |
NCBI chr10:61,824,208...61,858,924
Ensembl chr10:61,826,123...61,858,384
|
|
G |
Xbp1 |
X-box binding protein 1 |
|
IEP |
mRNA,protein:altered expression:cerebellum,hippocampus |
RGD |
PMID:16912310 |
RGD:32733622 |
NCBI chr14:80,390,629...80,395,713
Ensembl chr14:80,390,643...80,395,693
|
|
|
G |
C3 |
complement C3 |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:3361150 |
RGD:11041575 |
NCBI chr 9:2,087,437...2,114,366
Ensembl chr 9:2,087,437...2,114,429
|
|
G |
Cfb |
complement factor B |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:3361150 |
RGD:11041575 |
NCBI chr20:3,970,643...3,976,510
Ensembl chr20:3,951,474...3,976,505
|
|
G |
Cxcl10 |
C-X-C motif chemokine ligand 10 |
|
ISO |
|
RGD |
PMID:14507644 |
RGD:5135450 |
NCBI chr14:15,704,772...15,706,969
Ensembl chr14:15,704,758...15,706,975
|
|
G |
Cxcl9 |
C-X-C motif chemokine ligand 9 |
|
ISO |
|
RGD |
PMID:14507644 |
RGD:5135450 |
NCBI chr14:15,722,868...15,727,779
Ensembl chr14:15,722,908...15,728,435
|
|
|
G |
Il23a |
interleukin 23 subunit alpha |
|
ISO |
|
RGD |
PMID:16923792 |
RGD:39457937 |
NCBI chr 7:721,809...723,923
Ensembl chr 7:721,809...723,923
|
|
G |
Il4 |
interleukin 4 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:17387165 |
|
NCBI chr10:37,771,203...37,776,750
Ensembl chr10:37,771,203...37,776,750
|
|
|
G |
Birc2 |
baculoviral IAP repeat-containing 2 |
|
ISO |
mRNA:increased expression:perianal skin (human) |
RGD |
PMID:20346172 |
RGD:152998971 |
NCBI chr 8:4,968,856...4,989,325
Ensembl chr 8:4,968,842...4,988,732
|
|
G |
Birc3 |
baculoviral IAP repeat-containing 3 |
|
ISO |
mRNA:increased expression:perianal skin (human) |
RGD |
PMID:20346172 |
RGD:152998971 |
NCBI chr 8:5,000,844...5,028,470
Ensembl chr 8:5,000,845...5,015,802
|
|
|
G |
Tlr2 |
toll-like receptor 2 |
|
ISO |
|
RGD |
PMID:16239543 |
RGD:8552881 |
NCBI chr 2:169,200,620...169,206,819
Ensembl chr 2:169,197,419...169,206,630
|
|
|
G |
Cd163 |
CD163 molecule |
treatment |
ISO |
|
RGD |
PMID:32069255 |
RGD:149735531 |
NCBI chr 4:157,085,080...157,118,470
Ensembl chr 4:157,085,093...157,117,878
|
|
G |
Ifng |
interferon gamma |
treatment |
ISO |
|
RGD |
PMID:27916101 |
RGD:14974260 |
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
|
|
G |
Npc1 |
NPC intracellular cholesterol transporter 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12183525 |
|
NCBI chr18:3,379,482...3,425,100
Ensembl chr18:3,379,482...3,425,049
|
|
G |
Pde4a |
phosphodiesterase 4A |
|
IEP |
mRNA:decreased expression:spleen |
RGD |
PMID:17397885 |
RGD:2302429 |
NCBI chr 8:19,690,816...19,753,538
Ensembl chr 8:19,703,290...19,751,961
|
|
G |
Prdx5 |
peroxiredoxin 5 |
|
ISO |
mRNA:increased expression:spleen (mouse) |
RGD |
PMID:31196623 |
RGD:41404681 |
NCBI chr 1:204,099,826...204,103,589
Ensembl chr 1:204,099,826...204,114,268
|
|
G |
Sting1 |
stimulator of interferon response cGAMP interactor 1 |
|
ISO |
|
RGD |
PMID:29203515 PMID:30894428 |
RGD:39128199, RGD:39128234 |
NCBI chr18:27,332,119...27,338,371
Ensembl chr18:27,332,119...27,338,335
|
|
|
G |
Slc11a1 |
solute carrier family 11 member 1 |
susceptibility |
ISO |
ClinVar Annotator: match by term: Buruli ulcer, susceptibility to | ClinVar Annotator: match by term: SLC11A1-related condition CTD Direct Evidence: marker/mechanism |
OMIM ClinVar CTD |
PMID:16395392 PMID:28492532 |
|
NCBI chr 9:75,957,193...75,968,115
Ensembl chr 9:75,957,316...75,968,101
|
|
|
G |
Il23a |
interleukin 23 subunit alpha |
|
ISO |
|
RGD |
PMID:27322540 PMID:27385977 |
RGD:39457954, RGD:39458040 |
NCBI chr 7:721,809...723,923
Ensembl chr 7:721,809...723,923
|
|
G |
Pik3cg |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma |
treatment |
ISO |
|
RGD |
PMID:23180818 |
RGD:38599193 |
NCBI chr 6:48,766,778...48,802,098
Ensembl chr 6:48,766,864...48,802,043
|
|
G |
Slc11a1 |
solute carrier family 11 member 1 |
|
ISO |
|
RGD |
PMID:18656410 |
RGD:5684976 |
NCBI chr 9:75,957,193...75,968,115
Ensembl chr 9:75,957,316...75,968,101
|
|
|
G |
Cd1d1 |
CD1d1 molecule |
ameliorates |
ISO |
associated with endotoxemia |
RGD |
PMID:32154791 |
RGD:127345119 |
NCBI chr 2:172,423,582...172,427,089
Ensembl chr 2:172,423,582...172,427,089
|
|
G |
Ephb2 |
Eph receptor B2 |
exacerbates |
ISO |
|
RGD |
PMID:33685996 |
RGD:127229905 |
NCBI chr 5:148,889,574...149,077,027
Ensembl chr 5:148,897,246...149,077,059
|
|
|
G |
Aire |
autoimmune regulator |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12050215 |
|
NCBI chr20:10,636,058...10,651,060
Ensembl chr20:10,636,123...10,651,060
|
|
G |
Chrm2 |
cholinergic receptor, muscarinic 2 |
|
ISO |
|
RGD |
PMID:19958780 |
RGD:5509581 |
NCBI chr 4:65,015,408...65,149,104
Ensembl chr 4:65,014,144...65,149,103
|
|
G |
Il33 |
interleukin 33 |
treatment |
ISO |
|
RGD |
PMID:22661085 |
RGD:40400896 |
NCBI chr 1:227,701,964...227,736,374
Ensembl chr 1:227,721,435...227,736,373
|
|
G |
Ltf |
lactotransferrin |
|
ISO |
|
RGD |
PMID:17922408 |
RGD:7243948 |
NCBI chr 8:110,999,948...111,022,795
Ensembl chr 8:110,999,948...111,022,795
|
|
G |
Mapk8 |
mitogen-activated protein kinase 8 |
ameliorates |
ISO |
|
RGD |
PMID:28112734 |
RGD:150340684 |
NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981
|
|
G |
Ncr1 |
natural cytotoxicity triggering receptor 1 |
disease_progression |
ISO |
|
RGD |
PMID:27736647 |
RGD:40818241 |
NCBI chr 1:69,614,744...69,622,594
Ensembl chr 1:69,616,601...69,660,558
|
|
G |
Ripk3 |
receptor-interacting serine-threonine kinase 3 |
exacerbates |
ISO |
|
RGD |
PMID:30944411 |
RGD:127229913 |
NCBI chr15:29,283,153...29,292,107
Ensembl chr15:29,283,145...29,292,121
|
|
|
G |
Clec7a |
C-type lectin domain containing 7A |
|
ISO |
ClinVar Annotator: match by term: CLEC7A-related condition | ClinVar Annotator: match by term: Familial chronic mucocutaneous candidiasis CTD Direct Evidence: marker/mechanism |
ClinVar OMIM CTD |
PMID:19864674 PMID:20807886 PMID:24033266 PMID:25741868 PMID:28492532 |
|
NCBI chr 4:162,902,731...162,913,931
Ensembl chr 4:162,902,732...162,913,897
|
|
|
G |
Il17f |
interleukin 17F |
|
ISO |
ClinVar Annotator: match by term: Candidiasis, familial, 6 | ClinVar Annotator: match by term: IL17F-related condition |
OMIM ClinVar |
PMID:9536098 PMID:16199547 PMID:17576681 PMID:21350122 PMID:24033266 PMID:25741868 PMID:28492532 PMID:29458167 PMID:30290665 PMID:32047491 PMID:32185379 PMID:34587561 PMID:35753512 PMID:35874679 More...
|
|
NCBI chr 9:23,190,094...23,201,482
Ensembl chr 9:23,190,100...23,201,482
|
|
|
G |
Traf3ip2 |
Traf3 interacting protein 2 |
|
ISO |
ClinVar Annotator: match by term: Candidiasis, familial, 8 | ClinVar Annotator: match by term: TRAF3IP2-related condition |
ClinVar OMIM |
PMID:9536098 PMID:16199547 PMID:17576681 PMID:20953186 PMID:20953188 PMID:22513239 PMID:22581863 PMID:24033266 PMID:24120361 PMID:25741868 PMID:28492532 More...
|
|
NCBI chr20:43,011,405...43,054,654
Ensembl chr20:43,011,450...43,054,667
|
|
|
G |
Brk1 |
BRICK1 subunit of SCAR/WAVE actin nucleating complex |
|
ISO |
ClinVar Annotator: match by term: Candidiasis, familial, 9 |
ClinVar |
PMID:28492532 |
|
NCBI chr 4:146,750,821...146,766,050
Ensembl chr 4:146,750,821...146,768,856
|
|
G |
Cidec |
cell death-inducing DFFA-like effector c |
|
ISO |
ClinVar Annotator: match by term: Candidiasis, familial, 9 |
ClinVar |
PMID:28492532 |
|
NCBI chr 4:146,569,288...146,582,173
Ensembl chr 4:146,569,289...146,582,173
|
|
G |
Creld1 |
cysteine-rich with EGF-like domains 1 |
|
ISO |
ClinVar Annotator: match by term: Candidiasis, familial, 9 |
ClinVar |
PMID:25741868 PMID:28492532 |
|
NCBI chr 4:146,631,883...146,641,493
Ensembl chr 4:146,631,883...146,641,499
|
|
G |
Emc3 |
ER membrane protein complex subunit 3 |
|
ISO |
ClinVar Annotator: match by term: Candidiasis, familial, 9 |
ClinVar |
PMID:28492532 |
|
NCBI chr 4:146,663,065...146,678,976
Ensembl chr 4:146,663,067...146,679,029
|
|
G |
Fancd2 |
FA complementation group D2 |
|
ISO |
ClinVar Annotator: match by term: Candidiasis, familial, 9 |
ClinVar |
PMID:28492532 |
|
NCBI chr 4:146,679,014...146,743,422
Ensembl chr 4:146,679,179...146,743,412
|
|
G |
Fancd2os |
FANCD2 opposite strand |
|
ISO |
ClinVar Annotator: match by term: Candidiasis, familial, 9 |
ClinVar |
PMID:28492532 |
|
NCBI chr 4:146,740,863...146,747,547
Ensembl chr 4:146,740,863...146,747,569
|
|
G |
Il17rc |
interleukin 17 receptor C |
|
ISO |
ClinVar Annotator: match by term: Candidiasis, familial, 9 | ClinVar Annotator: match by term: IL17RC-related condition |
OMIM ClinVar |
PMID:9536098 PMID:16199547 PMID:17576681 PMID:25741868 PMID:25918342 PMID:28492532 More...
|
|
NCBI chr 4:146,618,321...146,631,444
Ensembl chr 4:146,619,004...146,631,442
|
|
G |
Il17re |
interleukin 17 receptor E |
|
ISO |
ClinVar Annotator: match by term: Candidiasis, familial, 9 |
ClinVar |
PMID:28492532 |
|
NCBI chr 4:146,604,547...146,618,206
Ensembl chr 4:146,605,526...146,618,206
|
|
G |
Jagn1 |
jagunal homolog 1 |
|
ISO |
ClinVar Annotator: match by term: Candidiasis, familial, 9 |
ClinVar |
PMID:28492532 |
|
NCBI chr 4:146,591,577...146,596,287
Ensembl chr 4:146,591,510...146,596,288
|
|
G |
Prrt3 |
proline-rich transmembrane protein 3 |
|
ISO |
ClinVar Annotator: match by term: Candidiasis, familial, 9 |
ClinVar |
PMID:28492532 |
|
NCBI chr 4:146,641,173...146,650,487
Ensembl chr 4:146,641,173...146,650,317
|
|
G |
Vhl |
von Hippel-Lindau tumor suppressor |
|
ISO |
ClinVar Annotator: match by term: Candidiasis, familial, 9 |
ClinVar |
PMID:28492532 |
|
NCBI chr 4:146,772,483...146,779,376
Ensembl chr 4:146,772,468...146,779,377
|
|
|
G |
Sod2 |
superoxide dismutase 2 |
|
ISO |
|
RGD |
PMID:15337840 |
RGD:1581246 |
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
|
|
|
G |
Gria1 |
glutamate ionotropic receptor AMPA type subunit 1 |
|
IEP |
mRNA:increased expression:hippocampus (rat) |
RGD |
PMID:19660546 |
RGD:2325963 |
NCBI chr10:41,210,713...41,527,283
Ensembl chr10:41,210,713...41,527,283
|
|
G |
Grin2a |
glutamate ionotropic receptor NMDA type subunit 2A |
|
IEP |
mRNA:increased expression:hippocampus (rat) |
RGD |
PMID:19660546 |
RGD:2325963 |
NCBI chr10:5,629,683...6,053,262
Ensembl chr10:5,631,369...6,044,637
|
|
G |
Plat |
plasminogen activator, tissue type |
|
IEP |
protein:increased expression:cerebellum (rat) |
RGD |
PMID:19279110 |
RGD:11537478 |
NCBI chr16:69,240,582...69,265,177
Ensembl chr16:69,240,585...69,268,223
|
|
|
G |
Prnp |
prion protein |
|
ISO |
ClinVar Annotator: match by term: Amyloidosis cerebral with spongiform encephalopathy |
ClinVar |
PMID:1353341 PMID:1363810 PMID:1672296 PMID:1674033 PMID:1677164 PMID:1682813 PMID:1684089 PMID:1971924 PMID:2180366 PMID:2190844 PMID:2378641 PMID:2564168 PMID:2572450 PMID:2783132 PMID:7902693 PMID:7902971 PMID:7908444 PMID:8137139 PMID:8461023 PMID:8698234 PMID:8880705 PMID:9643750 PMID:9653185 PMID:9748018 PMID:9751723 PMID:9789072 PMID:10079068 PMID:10437852 PMID:10526198 PMID:10581230 PMID:10953203 PMID:10970892 PMID:11488277 PMID:11506406 PMID:11506411 PMID:11749972 PMID:11756597 PMID:11840201 PMID:11967261 PMID:12172394 PMID:12451207 PMID:12601712 PMID:12867116 PMID:12891686 PMID:14520676 PMID:14562104 PMID:14761942 PMID:14872044 PMID:14970845 PMID:15277640 PMID:15539564 PMID:15967879 PMID:15987701 PMID:16025285 PMID:16217673 PMID:16315279 PMID:16369046 PMID:16380907 PMID:16391566 PMID:16565881 PMID:16969862 PMID:17029785 PMID:17494694 PMID:17666888 PMID:18955686 PMID:19422533 PMID:19422537 PMID:19680558 PMID:19696976 PMID:19703264 PMID:19923577 PMID:20301407 PMID:20583301 PMID:20592908 PMID:20932979 PMID:21269331 PMID:21839748 PMID:21909425 PMID:21983261 PMID:22097954 PMID:22108575 PMID:22561193 PMID:22947063 PMID:22999564 PMID:23132868 PMID:23176099 PMID:23320809 PMID:23527023 PMID:23555862 PMID:23668481 PMID:24583440 PMID:24838726 PMID:25482600 PMID:25741868 PMID:25818675 PMID:25959220 PMID:26268049 PMID:26323476 PMID:26578040 PMID:26740554 PMID:26791950 PMID:27341347 PMID:28492532 PMID:29382530 PMID:29704165 PMID:29887139 PMID:32998248 More...
|
|
NCBI chr 3:119,186,073...119,201,513
Ensembl chr 3:119,177,485...119,203,937
|
|
|
G |
Ace2 |
angiotensin converting enzyme 2 |
susceptibility |
ISO |
DNA:SNP:intron 1: C>T |
RGD |
PMID:20117248 |
RGD:40818420 |
NCBI chr X:30,293,597...30,340,961
Ensembl chr X:30,293,589...30,340,977
|
|
G |
Aqp4 |
aquaporin 4 |
disease_progression |
ISO |
protein:increased expression:astrocyte: |
RGD |
PMID:21904632 |
RGD:8698661 |
NCBI chr18:6,507,903...6,524,558
Ensembl chr18:6,507,903...6,524,856
|
|
G |
Cast |
calpastatin |
|
ISO |
protein:increased express:brain |
RGD |
PMID:16236382 |
RGD:5509817 |
NCBI chr 2:3,973,112...4,082,658
Ensembl chr 2:3,973,112...4,082,659
|
|
G |
Cd36 |
CD36 molecule |
|
ISO |
|
RGD |
PMID:17367535 |
RGD:6893527 |
NCBI chr 4:17,317,343...17,410,084
Ensembl chr 4:17,354,466...17,513,903
|
|
G |
Clec12a |
C-type lectin domain family 12, member A |
ameliorates |
ISO |
|
RGD |
PMID:31269448 |
RGD:41412201 |
NCBI chr 4:162,798,125...162,816,757
Ensembl chr 4:162,798,125...162,816,753
|
|
G |
Il1rl1 |
interleukin 1 receptor-like 1 |
treatment |
ISO |
|
RGD |
PMID:25682948 |
RGD:40400741 |
NCBI chr 9:42,661,694...42,727,266
Ensembl chr 9:42,697,192...42,727,256
|
|
G |
Il33 |
interleukin 33 |
treatment |
ISO |
protein:increased expression:brain |
RGD |
PMID:25659095 PMID:25682948 |
RGD:39938955, RGD:40400741 |
NCBI chr 1:227,701,964...227,736,374
Ensembl chr 1:227,721,435...227,736,373
|
|
G |
Jak3 |
Janus kinase 3 |
|
ISO |
|
RGD |
PMID:22363534 |
RGD:11531103 |
NCBI chr16:18,386,330...18,398,542
Ensembl chr16:18,386,405...18,398,536
|
|
G |
Lta |
lymphotoxin alpha |
|
ISO |
|
RGD |
PMID:12021316 |
RGD:10449455 |
NCBI chr20:3,618,853...3,621,324
Ensembl chr20:3,618,853...3,620,859
|
|
G |
Nrg1 |
neuregulin 1 |
treatment |
ISO |
mRNA, protein:increased expression:cerebral cortex (mouse) human protein in a mouse model |
RGD |
PMID:29636063 PMID:24433482 |
RGD:39456084, RGD:39456102 |
NCBI chr16:59,250,658...60,304,519
Ensembl chr16:59,250,854...60,296,884
|
|
G |
Pik3cg |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma |
|
ISO |
|
RGD |
PMID:25775137 |
RGD:38599200 |
NCBI chr 6:48,766,778...48,802,098
Ensembl chr 6:48,766,864...48,802,043
|
|
G |
Prkaa2 |
protein kinase AMP-activated catalytic subunit alpha 2 |
|
ISO |
mRNA:decreased expression:brain (mouse) |
RGD |
PMID:29107705 |
RGD:39456137 |
NCBI chr 5:119,807,992...119,879,987
Ensembl chr 5:119,813,226...119,879,543
|
|
G |
Tnfrsf1b |
TNF receptor superfamily member 1B |
|
ISO |
|
RGD |
PMID:12228317 |
RGD:5131158 |
NCBI chr 5:157,070,642...157,104,216
Ensembl chr 5:157,070,642...157,104,206
|
|
|
G |
Nfkb1 |
nuclear factor kappa B subunit 1 |
severity |
ISO |
|
RGD |
PMID:20156658 |
RGD:40902838 |
NCBI chr 2:224,016,214...224,132,135
Ensembl chr 2:224,016,214...224,110,404
|
|
|
G |
Ccr5 |
C-C motif chemokine receptor 5 |
|
ISO |
|
RGD |
PMID:16118671 |
RGD:8549760 |
NCBI chr 8:123,752,423...123,757,538
Ensembl chr 8:123,752,325...123,759,260
|
|
G |
Cd40 |
CD40 molecule |
|
ISO |
|
RGD |
PMID:20102413 |
RGD:5132268 |
NCBI chr 3:153,790,372...153,805,279
Ensembl chr 3:153,790,449...153,805,534
|
|
G |
Foxp3 |
forkhead box P3 |
treatment |
ISO |
|
RGD |
PMID:30832593 |
RGD:38455984 |
NCBI chr X:14,908,494...14,924,994
Ensembl chr X:14,908,494...14,923,838
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
|
ISO |
mRNA:increased expression:lung (mouse) |
RGD |
PMID:19728926 |
RGD:4145507 |
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
|
|
G |
Ido1 |
indoleamine 2,3-dioxygenase 1 |
treatment |
ISO |
mRNA:increased expression:lung (mouse) |
RGD |
PMID:30832593 PMID:31249813 |
RGD:38455984, RGD:39938856 |
NCBI chr16:67,430,654...67,442,726
Ensembl chr16:67,430,578...67,442,730
|
|
G |
Ifng |
interferon gamma |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19203382 |
|
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
|
|
G |
Il13 |
interleukin 13 |
|
ISO |
|
RGD |
PMID:21573182 |
RGD:5684365 |
NCBI chr10:37,790,130...37,792,687
Ensembl chr10:37,790,130...37,792,737
|
|
G |
Il17a |
interleukin 17A |
|
ISO |
associated with Bronchial Hyprractivity; mRNA:increased expression:lung |
RGD |
PMID:20228193 PMID:19812198 |
RGD:4888528, RGD:4889101 |
NCBI chr 9:23,144,402...23,147,889
Ensembl chr 9:23,144,402...23,147,889
|
|
G |
Mir21 |
microRNA 21 |
|
ISO |
associated with asthma;RNA:increased expression:lung |
RGD |
PMID:27448447 |
RGD:41404696 |
NCBI chr10:71,902,600...71,902,691
Ensembl chr10:71,405,257...71,405,348
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
treatment |
ISO |
|
RGD |
PMID:30832593 |
RGD:38455984 |
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
|
|
G |
Tnf |
tumor necrosis factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19203382 |
|
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,622,011...3,624,629
|
|
|
G |
Cd274 |
CD274 molecule |
|
ISO |
mRNA:increased expression:lung |
RGD |
PMID:26378990 |
RGD:41412180 |
NCBI chr 1:227,116,674...227,137,379
Ensembl chr 1:227,116,649...227,134,450
|
|
G |
Pdcd1 |
programmed cell death 1 |
|
ISO |
mRNA:increased expression:lung |
RGD |
PMID:26378990 |
RGD:41412180 |
NCBI chr 9:94,418,786...94,431,945
Ensembl chr 9:94,418,791...94,431,937
|
|
G |
Pik3cd |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta |
severity |
ISO |
|
RGD |
PMID:29893841 |
RGD:40890270 |
NCBI chr 5:160,094,952...160,142,962
Ensembl chr 5:160,094,952...160,120,930
|
|
|
G |
Cd1d1 |
CD1d1 molecule |
|
ISO |
|
RGD |
PMID:23999314 |
RGD:127345116 |
NCBI chr 2:172,423,582...172,427,089
Ensembl chr 2:172,423,582...172,427,089
|
|
G |
Plac8 |
placenta associated 8 |
severity exacerbates |
ISO |
|
RGD |
PMID:22238459 PMID:22238459 |
RGD:40925930, RGD:40925930 |
NCBI chr14:9,052,601...9,074,264
Ensembl chr14:9,063,048...9,074,264
|
|
G |
Pten |
phosphatase and tensin homolog |
|
ISO |
associated with Experimental Allergic Asthma;mRNA:decreased expression:lung (mouse) |
RGD |
PMID:27448447 |
RGD:41404696 |
NCBI chr 1:230,630,443...230,697,070
Ensembl chr 1:230,630,338...230,696,838
|
|
|
G |
Hdc |
histidine decarboxylase |
|
ISO |
|
RGD |
PMID:14556983 |
RGD:5143922 |
NCBI chr 3:113,847,256...113,865,334
Ensembl chr 3:113,847,260...113,865,341
|
|
G |
Lcn2 |
lipocalin 2 |
exacerbates |
ISO |
|
RGD |
PMID:23317919 |
RGD:126781720 |
NCBI chr 3:15,680,688...15,684,033
Ensembl chr 3:15,680,687...15,684,095
|
|
G |
Mmp14 |
matrix metallopeptidase 14 |
|
IEP |
|
RGD |
PMID:12526080 |
RGD:1582580 |
NCBI chr15:27,887,795...27,897,020
Ensembl chr15:27,887,727...27,899,864
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
|
ISO |
|
RGD |
PMID:12526080 |
RGD:1582580 |
NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870
|
|
|
G |
Duox2 |
dual oxidase 2 |
treatment |
ISO |
|
RGD |
PMID:29133347 |
RGD:40925924 |
NCBI chr 3:109,223,809...109,247,023
Ensembl chr 3:109,226,924...109,245,902
|
|
G |
Mir155 |
microRNA 155 |
|
ISO |
miRNA:increased expression:duodenum |
RGD |
PMID:28319200 |
RGD:25314323 |
NCBI chr11:37,261,114...37,261,178
Ensembl chr11:23,774,654...23,774,718
|
|
|
G |
Ifng |
interferon gamma |
treatment |
ISO |
|
RGD |
PMID:29481557 |
RGD:14975102 |
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
|
|
|
G |
Clec7a |
C-type lectin domain containing 7A |
|
ISO |
ClinVar Annotator: match by term: Candidiasis familial chronic mucocutaneous, autosomal recessive |
ClinVar |
PMID:19864674 PMID:20807886 PMID:24033266 PMID:25741868 |
|
NCBI chr 4:162,902,731...162,913,931
Ensembl chr 4:162,902,732...162,913,897
|
|
G |
Il17ra |
interleukin 17 receptor A |
|
ISO |
ClinVar Annotator: match by term: Chronic mucocutaneous candidiasis | ClinVar Annotator: match by term: Familial Candidiasis, Recessive |
ClinVar |
PMID:16670328 PMID:18802100 PMID:21178015 PMID:21350122 PMID:24033266 PMID:25741868 PMID:27930337 PMID:28492532 More...
|
|
NCBI chr 4:153,667,534...153,690,174
Ensembl chr 4:153,667,534...153,690,174
|
|
G |
Mapk8 |
mitogen-activated protein kinase 8 |
|
ISO |
associated with connective tissue disease;DNA:splice-site mutation:splice junction:c.311+1G>A (human) |
RGD |
PMID:31784499 |
RGD:150340677 |
NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981
|
|
G |
Stat1 |
signal transducer and activator of transcription 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Chronic mucocutaneous candidiasis |
CTD ClinVar |
PMID:21714643 PMID:21727188 PMID:23541320 PMID:23709754 PMID:24033266 PMID:24343863 PMID:25741868 PMID:26255980 PMID:26494717 PMID:26604104 PMID:28161409 PMID:28427548 PMID:28492532 PMID:28815025 More...
|
|
NCBI chr 9:49,419,561...49,459,969
Ensembl chr 9:49,419,340...49,588,540
|
|
|
G |
Acyp2 |
acylphosphatase 2 |
|
ISO |
ClinVar Annotator: match by term: Chronic osteomyelitis |
ClinVar |
|
|
NCBI chr14:104,201,894...104,371,415
Ensembl chr14:104,201,895...104,371,386
|
|
G |
Il1r1 |
interleukin 1 receptor type 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
|
|
NCBI chr 9:42,504,917...42,580,958
Ensembl chr 9:42,504,735...42,579,937
|
|
G |
Mlkl |
mixed lineage kinase domain like pseudokinase |
|
ISO |
ClinVar Annotator: match by term: Chronic multifocal osteomyelitis |
ClinVar |
|
|
NCBI chr19:39,277,526...39,304,555
Ensembl chr19:39,276,785...39,304,502
|
|
G |
Mynn |
myoneurin |
|
ISO |
ClinVar Annotator: match by term: Chronic osteomyelitis |
ClinVar |
|
|
NCBI chr 2:112,779,654...112,797,188
Ensembl chr 2:112,779,657...112,796,397
|
|
G |
Pstpip2 |
proline-serine-threonine phosphatase-interacting protein 2 |
|
ISS |
OMIM:259680 |
MouseDO |
|
|
NCBI chr18:71,310,387...71,396,752
Ensembl chr18:71,311,020...71,395,709
|
|
G |
Tert |
telomerase reverse transcriptase |
|
ISO |
ClinVar Annotator: match by term: Chronic osteomyelitis |
ClinVar |
PMID:16890917 PMID:25741868 PMID:28492532 |
|
NCBI chr 1:29,637,213...29,659,561
Ensembl chr 1:29,637,506...29,659,561
|
|
G |
Zbtb46 |
zinc finger and BTB domain containing 46 |
|
ISO |
ClinVar Annotator: match by term: Chronic osteomyelitis |
ClinVar |
|
|
NCBI chr 3:168,497,294...168,567,799
Ensembl chr 3:168,499,583...168,568,782
|
|
|
G |
Il1f10 |
interleukin 1 family member 10 |
|
ISO |
ClinVar Annotator: match by term: Sterile multifocal osteomyelitis with periostitis and pustulosis |
ClinVar |
PMID:19494218 PMID:21792839 PMID:22940634 PMID:23698098 PMID:26100510 PMID:28492532 More...
|
|
NCBI chr 3:7,072,511...7,075,439
Ensembl chr 3:7,072,511...7,075,439
|
|
G |
Il1rn |
interleukin 1 receptor antagonist |
|
ISO |
ClinVar Annotator: match by term: Sterile multifocal osteomyelitis with periostitis and pustulosis |
OMIM ClinVar |
PMID:9536098 PMID:12837270 PMID:16199547 PMID:16519819 PMID:17576681 PMID:19280228 PMID:19494218 PMID:19494219 PMID:19729864 PMID:20213597 PMID:20842532 PMID:21279638 PMID:21792839 PMID:22032624 PMID:22127713 PMID:22940634 PMID:23698098 PMID:24033266 PMID:24863340 PMID:25501066 PMID:25741868 PMID:26100510 PMID:28236224 PMID:28492532 PMID:32819369 More...
|
|
NCBI chr 3:7,111,567...7,127,451
Ensembl chr 3:7,111,550...7,127,445
|
|
G |
Il36rn |
interleukin 36 receptor antagonist |
|
ISO |
ClinVar Annotator: match by term: Sterile multifocal osteomyelitis with periostitis and pustulosis |
ClinVar |
PMID:19494218 PMID:21792839 PMID:22940634 PMID:23698098 PMID:26100510 PMID:28492532 More...
|
|
NCBI chr 3:7,044,419...7,051,016
Ensembl chr 3:7,044,406...7,051,016
|
|
G |
Nfkbia |
NFKB inhibitor alpha |
|
ISO |
ClinVar Annotator: match by term: Sterile multifocal osteomyelitis with periostitis and pustulosis |
ClinVar |
|
|
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
|
|
|
G |
Il1r1 |
interleukin 1 receptor type 1 |
|
ISO |
ClinVar Annotator: match by term: Chronic recurrent multifocal osteomyelitis 3 |
OMIM ClinVar |
|
|
NCBI chr 9:42,504,917...42,580,958
Ensembl chr 9:42,504,735...42,579,937
|
|
|
G |
Il23a |
interleukin 23 subunit alpha |
severity |
ISO |
|
RGD |
PMID:26455347 |
RGD:11097134 |
NCBI chr 7:721,809...723,923
Ensembl chr 7:721,809...723,923
|
|
G |
Il33 |
interleukin 33 |
treatment severity |
ISO |
|
RGD |
PMID:32156806 PMID:32156806 |
RGD:40400894, RGD:40400894 |
NCBI chr 1:227,701,964...227,736,374
Ensembl chr 1:227,721,435...227,736,373
|
|
|
G |
Il27 |
interleukin 27 |
|
ISO |
associated with diarrhea;protein:increased expression:blood��serum, feces (human) |
RGD |
PMID:29140433 |
RGD:126790495 |
NCBI chr 1:181,173,108...181,178,720
Ensembl chr 1:181,173,372...181,178,582
|
|
G |
Marco |
macrophage receptor with collagenous structure |
exacerbates |
ISO |
|
RGD |
PMID:20810988 |
RGD:41412193 |
NCBI chr13:31,616,278...31,648,521
Ensembl chr13:31,616,278...31,648,521
|
|
|
G |
Mbl2 |
mannose binding lectin 2 |
|
ISO |
protein:decreased secretion:serum (human) |
RGD |
PMID:19083122 |
RGD:4889458 |
NCBI chr 1:228,016,439...228,024,736
|
|
|
G |
RT1-Ba |
RT1 class II, locus Ba |
susceptibility |
ISO |
DNA:polymorphisms: :HLA-DQA1*01:03, HLA-DQA1*03:02 (human) |
RGD |
PMID:26856406 |
RGD:126928144 |
NCBI chr20:4,575,134...4,579,727
Ensembl chr20:4,575,134...4,579,744
|
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
|
ISO |
ClinVar Annotator: match by term: Coronary artery disease, development of, in HIV |
ClinVar |
PMID:11500196 PMID:15466648 PMID:16352737 PMID:16596675 PMID:18940815 |
|
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
|
|
|
G |
Aldh1a1 |
aldehyde dehydrogenase 1 family, member A1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23349890 |
|
NCBI chr 1:218,000,470...218,152,962
Ensembl chr 1:218,042,127...218,152,961
|
|
G |
Atf6 |
activating transcription factor 6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23349890 |
|
NCBI chr13:82,927,579...83,106,381
Ensembl chr13:82,930,034...83,107,177
|
|
G |
Cped1 |
cadherin-like and PC-esterase domain containing 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23349890 |
|
NCBI chr 4:50,516,712...50,789,651
Ensembl chr 4:50,516,819...50,788,674
|
|
G |
Ctss |
cathepsin S |
|
ISO |
|
RGD |
PMID:12368333 |
RGD:5686913 |
NCBI chr 2:183,086,437...183,114,483
Ensembl chr 2:183,086,437...183,114,483
|
|
G |
Galc |
galactosylceramidase |
|
ISO |
mRNA:decreased expression:frontal cortex (human) |
RGD |
PMID:30009661 |
RGD:38599170 |
NCBI chr 6:117,452,888...117,522,281
Ensembl chr 6:117,452,895...117,515,830
|
|
G |
Il1a |
interleukin 1 alpha |
|
ISO |
mRNA:increased expression:brain: |
RGD |
PMID:8790403 |
RGD:10045948 |
NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822
|
|
G |
Klrc2 |
killer cell lectin like receptor C2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23349890 |
|
NCBI chr 4:163,122,700...163,133,843
Ensembl chr 4:163,122,704...163,133,843
|
|
G |
Krt73 |
keratin 73 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23349890 |
|
NCBI chr 7:132,927,812...132,936,323
Ensembl chr 7:132,928,256...132,936,280
|
|
G |
Mapt |
microtubule-associated protein tau |
|
ISO |
protein:increased expression:CSF (human) protein:increased expression:CSF, serum (human) |
RGD |
PMID:31541342 PMID:29368621 PMID:27929120 PMID:30309804 |
RGD:127284880, RGD:127284889, RGD:127284887, RGD:127284881 |
NCBI chr10:89,138,644...89,236,137
Ensembl chr10:89,138,627...89,236,129
|
|
G |
Msl3l2 |
male-specific lethal 3-like 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23349890 |
|
NCBI chr20:35,468,877...35,477,025
Ensembl chr20:35,468,888...35,477,757
|
|
G |
Nefh |
neurofilament heavy chain |
|
ISO |
protein:increased expression:CSF (human) |
RGD |
PMID:27929120 |
RGD:127284887 |
NCBI chr14:79,830,362...79,840,347
Ensembl chr14:79,830,362...79,840,351
|
|
G |
Nefl |
neurofilament light chain |
|
ISO |
protein:increased expression:CSF (human) protein:increased expression:CSF, serum (human) |
RGD |
PMID:31541342 PMID:29368621 PMID:27929120 PMID:30309804 |
RGD:127284880, RGD:127284889, RGD:127284887, RGD:127284881 |
NCBI chr15:42,301,920...42,305,793
Ensembl chr15:42,301,916...42,305,793
|
|
G |
Prnp |
prion protein |
susceptibility |
ISO ISS |
DNA:mutation ClinVar Annotator: match by term: Creutzfeldt-Jakob Disease, Familial OMIM:123400 CTD Direct Evidence: marker/mechanism |
OMIM ClinVar MouseDO CTD RGD |
PMID:1351274 PMID:1353341 PMID:1404799 PMID:1469441 PMID:1672296 PMID:1674033 PMID:1677164 PMID:1682813 PMID:1684089 PMID:1684755 PMID:1684758 PMID:1798423 PMID:1971924 PMID:1975028 PMID:2180366 PMID:2190844 PMID:2253724 PMID:2378641 PMID:2458274 PMID:2564168 PMID:2572450 PMID:2783132 PMID:7902693 PMID:7902971 PMID:7908444 PMID:7916462 PMID:7936296 PMID:7999318 PMID:8105682 PMID:8137139 PMID:8461023 PMID:8618678 PMID:8698234 PMID:8880705 PMID:8909447 PMID:9279329 PMID:9643750 PMID:9653185 PMID:9748018 PMID:9751723 PMID:9789072 PMID:9813003 PMID:10079068 PMID:10090891 PMID:10360778 PMID:10437852 PMID:10526198 PMID:10581230 PMID:10665501 PMID:10889050 PMID:10953203 PMID:11488277 PMID:11506406 PMID:11506411 PMID:11749972 PMID:11756597 PMID:11839833 PMID:11840201 PMID:11967261 PMID:12172394 PMID:12451207 PMID:12572668 PMID:12601712 PMID:12867116 PMID:12891686 PMID:14520676 PMID:14562104 PMID:14761942 PMID:14872044 PMID:14967768 PMID:14970845 PMID:15277640 PMID:15366237 PMID:15539564 PMID:15739100 PMID:15753435 PMID:15776279 PMID:15967879 PMID:15987701 PMID:16187142 PMID:16217673 PMID:16314483 PMID:16315279 PMID:16369046 PMID:16380907 PMID:16391566 PMID:16533975 PMID:16565881 PMID:16969862 PMID:17029785 PMID:17494694 PMID:17666888 PMID:18955686 PMID:19422533 PMID:19422537 PMID:19696976 PMID:19703264 PMID:19923577 PMID:20139714 PMID:20301407 PMID:20514992 PMID:20541558 PMID:20583301 PMID:20592908 PMID:20593190 PMID:20932979 PMID:21269331 PMID:21298055 PMID:21552571 PMID:21791975 PMID:21839748 PMID:21909425 PMID:21983261 PMID:22072968 PMID:22097954 PMID:22108575 PMID:22318125 PMID:22488860 PMID:22561193 PMID:22584955 PMID:22947063 PMID:22965875 PMID:22999564 PMID:23132868 PMID:23176099 PMID:23296137 PMID:23320809 PMID:23349890 PMID:23527023 PMID:23555862 PMID:23668481 PMID:23723004 PMID:24583440 PMID:24838726 PMID:25064618 PMID:25279981 PMID:25450391 PMID:25482600 PMID:25522698 PMID:25741868 PMID:25818675 PMID:25959220 PMID:26268049 PMID:26488179 PMID:26578040 PMID:26740554 PMID:26791950 PMID:27341347 PMID:27803826 PMID:28492532 PMID:29382530 PMID:29704165 PMID:29887139 PMID:32998248 PMID:1684755 More...
|
RGD:1599946 |
NCBI chr 3:119,186,073...119,201,513
Ensembl chr 3:119,177,485...119,203,937
|
|
G |
Ptgs1 |
prostaglandin-endoperoxide synthase 1 |
|
ISO |
mRNA, protein:increased expression:macrophage, endothelial cell |
RGD |
PMID:12663931 |
RGD:5688237 |
NCBI chr 3:19,584,015...19,605,589
Ensembl chr 3:19,584,015...19,605,586
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
ISO |
mRNA, protein:increased expression:neuron |
RGD |
PMID:12663931 |
RGD:5688237 |
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
|
|
G |
RT1-Bb |
RT1 class II, locus Bb |
susceptibility |
ISO |
CTD Direct Evidence: marker/mechanism |
CTD OMIM |
|
|
NCBI chr20:4,596,558...4,602,201
Ensembl chr20:4,596,559...4,607,597
|
|
G |
S100b |
S100 calcium binding protein B |
|
ISO |
protein:increased expression:serum (human) |
RGD |
PMID:20855493 PMID:27929120 |
RGD:5508781, RGD:127284887 |
NCBI chr20:12,372,866...12,381,619
Ensembl chr20:12,372,881...12,394,743
|
|
G |
Serpina3m |
serpin family A member 3M |
disease_progression |
ISO |
mRNA,protein:increased expression:frontal cortex: |
RGD |
PMID:29142239 PMID:29142239 |
RGD:36947868, RGD:36947868 |
NCBI chr 6:123,064,796...123,072,087
Ensembl chr 6:123,064,796...123,072,066
|
|
G |
Serpina3n |
serpin family A member 3N |
|
ISO |
mRNA,protein:increased expression:frontal cortex: |
RGD |
PMID:29142239 |
RGD:36947868 |
NCBI chr 6:123,323,623...123,331,181
Ensembl chr 6:123,323,629...123,332,433
|
|
G |
Snca |
synuclein alpha |
|
ISO |
protein:increased expression:cerebral spinal fluid: |
RGD |
PMID:18625222 |
RGD:13506723 |
NCBI chr 4:89,696,420...89,797,240
Ensembl chr 4:89,696,420...89,796,262
|
|
G |
Snora16b |
small nucleolar RNA, H/ACA box 16B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23349890 |
|
NCBI chr 8:2,368,882...2,369,014
Ensembl chr 8:2,368,882...2,369,014
|
|
G |
Srd5a3 |
steroid 5 alpha-reductase 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23349890 |
|
NCBI chr14:32,046,408...32,060,796
Ensembl chr14:32,046,408...32,060,747
|
|
G |
Stx1a |
syntaxin 1A |
|
ISO |
|
RGD |
PMID:10842016 |
RGD:1581434 |
NCBI chr12:21,641,971...21,670,022
Ensembl chr12:21,641,969...21,669,930
|
|
G |
Tubb2a |
tubulin, beta 2A class IIa |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23349890 |
|
NCBI chr17:30,796,842...30,800,713
Ensembl chr17:30,747,503...30,800,714
|
|
G |
Ywhag |
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, gamma |
|
ISO |
protein:increased expression:CSF (human) |
RGD |
PMID:31541342 PMID:27929120 PMID:30309804 |
RGD:127284880, RGD:127284887, RGD:127284881 |
NCBI chr12:20,744,500...20,772,828
Ensembl chr12:20,744,535...20,772,827
|
|
|
G |
Ifna1 |
interferon, alpha 1 |
susceptibility |
ISO |
DNA:SNP:promoter: -1823G>A (rs1332190)(human) |
RGD |
PMID:26694082 |
RGD:36174029 |
NCBI chr 5:103,097,356...103,097,925
Ensembl chr 5:103,097,356...103,097,925
|
|
|
G |
Cd274 |
CD274 molecule |
treatment |
ISO |
|
RGD |
PMID:29058791 |
RGD:41412178 |
NCBI chr 1:227,116,674...227,137,379
Ensembl chr 1:227,116,649...227,134,450
|
|
G |
Mbl2 |
mannose binding lectin 2 |
susceptibility |
ISO |
associated with HIV Infections;DNA:polymorphism:cds: |
RGD |
PMID:21592999 |
RGD:12910861 |
NCBI chr 1:228,016,439...228,024,736
|
|
G |
Pdcd1 |
programmed cell death 1 |
treatment |
ISO |
|
RGD |
PMID:29058791 PMID:29058791 |
RGD:41412178, RGD:41412178 |
NCBI chr 9:94,418,786...94,431,945
Ensembl chr 9:94,418,791...94,431,937
|
|
|
G |
Btk |
Bruton tyrosine kinase |
exacerbates |
ISO |
|
RGD |
PMID:23820392 |
RGD:124715476 |
NCBI chr X:97,722,796...97,762,315
Ensembl chr X:97,722,802...97,761,853
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
|
ISO |
mRNA, protein:increased expression:lung (mouse) |
RGD |
PMID:11714821 |
RGD:11528563 |
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
|
|
G |
Cd40 |
CD40 molecule |
treatment |
ISO |
|
RGD |
PMID:16552046 |
RGD:7248435 |
NCBI chr 3:153,790,372...153,805,279
Ensembl chr 3:153,790,449...153,805,534
|
|
G |
Cd86 |
CD86 molecule |
|
ISO |
protein:increased expression:lung, dendritic cell (mouse) |
RGD |
PMID:16790753 |
RGD:4892554 |
NCBI chr11:64,142,193...64,200,816
Ensembl chr11:64,163,828...64,200,818
|
|
G |
Chia |
chitinase, acidic |
|
IEP |
protein:increased expression:lung (rat) |
RGD |
PMID:18482441 |
RGD:4990459 |
NCBI chr 2:193,614,374...193,656,532
Ensembl chr 2:193,614,114...193,656,533
|
|
G |
Il23a |
interleukin 23 subunit alpha |
severity |
ISO |
|
RGD |
PMID:16393998 PMID:22342846 |
RGD:39457936, RGD:39458042 |
NCBI chr 7:721,809...723,923
Ensembl chr 7:721,809...723,923
|
|
G |
Il33 |
interleukin 33 |
|
ISO |
mRNA:increased expression:lung (mouse) |
RGD |
PMID:27596810 |
RGD:38549345 |
NCBI chr 1:227,701,964...227,736,374
Ensembl chr 1:227,721,435...227,736,373
|
|
G |
Il4r |
interleukin 4 receptor |
|
ISO |
|
RGD |
PMID:18954266 |
RGD:4890005 |
NCBI chr 1:180,115,061...180,139,981
Ensembl chr 1:180,115,120...180,139,980
|
|
G |
Marco |
macrophage receptor with collagenous structure |
disease_progression |
ISO |
|
RGD |
PMID:28298522 |
RGD:41412191 |
NCBI chr13:31,616,278...31,648,521
Ensembl chr13:31,616,278...31,648,521
|
|
G |
Sftpc |
surfactant protein C |
|
ISO |
mRNA:increased expression:lung (mouse) |
RGD |
PMID:27596810 |
RGD:38549345 |
NCBI chr15:45,596,565...45,599,615
Ensembl chr15:45,596,574...45,610,777
|
|
|
G |
Mbl2 |
mannose binding lectin 2 |
susceptibility |
ISO |
DNA:SNP:exon:p.G54D(rs1800450)(human) |
RGD |
PMID:15249448 |
RGD:8693755 |
NCBI chr 1:228,016,439...228,024,736
|
|
G |
Muc5ac |
mucin 5AC, oligomeric mucus/gel-forming |
|
ISO |
protein:decreased expression:bronchiole epithelium |
RGD |
PMID:15364771 |
RGD:7364741 |
NCBI chr 1:196,864,336...196,896,475
Ensembl chr 1:196,864,336...196,896,475
|
|
G |
Muc5b |
mucin 5B, oligomeric mucus/gel-forming |
|
ISO |
DNA:insertion/deletion |
RGD |
PMID:15709052 |
RGD:7349353 |
NCBI chr 1:196,916,861...196,948,830
Ensembl chr 1:196,916,825...196,949,250
|
|
G |
Mucl3 |
mucin like 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22152429 |
|
NCBI chr20:3,100,652...3,108,569
Ensembl chr20:3,100,679...3,108,569
|
|
G |
Tap2 |
transporter 2, ATP binding cassette subfamily B member |
susceptibility |
ISO |
DNA:polymorphisms:exon: |
RGD |
PMID:10323341 |
RGD:5147847 |
NCBI chr20:4,636,347...4,650,387
Ensembl chr20:4,636,357...4,650,407
|
|
|
G |
Il21 |
interleukin 21 |
|
ISO |
protein:increased expression:CD4-positive helper T cell (mouse) |
RGD |
PMID:26597007 |
RGD:11086452 |
NCBI chr 2:120,117,105...120,127,012
Ensembl chr 2:120,119,444...120,126,996
|
|
|
G |
Casp3 |
caspase 3 |
treatment |
IEP |
|
RGD |
PMID:26920733 |
RGD:13782281 |
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp6 |
caspase 6 |
treatment |
IEP |
|
RGD |
PMID:26920733 |
RGD:13782281 |
NCBI chr 2:218,466,063...218,478,503
Ensembl chr 2:218,466,076...218,478,502
|
|
G |
Casp7 |
caspase 7 |
treatment |
IEP |
|
RGD |
PMID:26920733 |
RGD:13782281 |
NCBI chr 1:255,437,438...255,476,737
Ensembl chr 1:255,437,172...255,476,729
|
|
G |
Casp9 |
caspase 9 |
treatment |
IEP |
|
RGD |
PMID:26920733 |
RGD:13782281 |
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Il1a |
interleukin 1 alpha |
|
IEP |
protein:increased expression:endometrium |
RGD |
PMID:25330821 |
RGD:11059518 |
NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822
|
|
G |
Trem1 |
triggering receptor expressed on myeloid cells 1 |
ameliorates |
ISO |
|
RGD |
PMID:31365951 |
RGD:126928127 |
NCBI chr 9:12,763,819...12,779,285
Ensembl chr 9:12,763,819...12,779,203
|
|
|
G |
Abcb11 |
ATP binding cassette subfamily B member 11 |
|
IEP |
|
RGD |
PMID:9828229 |
RGD:1598596 |
NCBI chr 3:54,016,854...54,112,797
Ensembl chr 3:54,017,127...54,112,730
|
|
G |
Abcb1a |
ATP binding cassette subfamily B member 1A |
|
IEP |
mRNA:decreased expression:liver (rat) |
RGD |
PMID:26977098 |
RGD:11041000 |
NCBI chr 4:26,312,403...26,488,456
Ensembl chr 4:25,158,362...25,442,709
|
|
G |
Abcb1b |
ATP-binding cassette, sub-family B member 1B |
|
IEP ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:20300455 PMID:9828229 |
RGD:1598596 |
NCBI chr 4:25,242,761...25,325,194
Ensembl chr 4:25,242,798...25,325,199
|
|
G |
Abcc2 |
ATP binding cassette subfamily C member 2 |
|
IEP |
|
RGD |
PMID:16572733 |
RGD:1598611 |
NCBI chr 1:242,664,657...242,723,239
Ensembl chr 1:242,664,657...242,723,238
|
|
G |
Abcc8 |
ATP binding cassette subfamily C member 8 |
|
IEP |
|
RGD |
PMID:17285300 |
RGD:2301914 |
NCBI chr 1:96,598,568...96,679,563
Ensembl chr 1:96,598,647...96,679,510
|
|
G |
Ace |
angiotensin I converting enzyme |
|
IEP |
associated with Hemorrhage;protein:decreased activity:plasma (rat) |
RGD |
PMID:3028670 |
RGD:8142370 |
NCBI chr10:90,910,316...90,930,437
Ensembl chr10:90,910,316...90,931,131
|
|
G |
Ache |
acetylcholinesterase |
|
ISO |
|
RGD |
PMID:17657467 |
RGD:5688055 |
NCBI chr12:19,406,133...19,413,713
Ensembl chr12:19,407,360...19,413,651
|
|
G |
Actc1 |
actin, alpha, cardiac muscle 1 |
|
IEP |
|
RGD |
PMID:11680626 |
RGD:1598729 |
NCBI chr 3:100,811,987...100,817,523
Ensembl chr 3:100,811,987...100,817,523
|
|
G |
Adamts1 |
ADAM metallopeptidase with thrombospondin type 1 motif, 1 |
|
IEP |
protein:increased expression:plasma, spleen |
RGD |
PMID:23025351 |
RGD:9681752 |
NCBI chr11:24,932,227...24,941,068
Ensembl chr11:24,931,761...24,941,103
|
|
G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
IEP |
associated with Obesity |
RGD |
PMID:23838384 |
RGD:8695926 |
NCBI chr11:77,721,912...77,735,644
Ensembl chr11:77,721,912...77,735,564
|
|
G |
Adipor2 |
adiponectin receptor 2 |
severity |
IEP |
associated with obesity;mRNA:decreased expression:liver (rat) |
RGD |
PMID:23838384 |
RGD:8695926 |
NCBI chr 4:152,524,604...152,588,848
Ensembl chr 4:152,524,623...152,559,355
|
|
G |
Adra2a |
adrenoceptor alpha 2A |
onset |
IEP |
mRNA:increased expression:spleen |
RGD |
PMID:20302880 |
RGD:6480487 |
NCBI chr 1:253,061,480...253,064,280
Ensembl chr 1:253,060,218...253,064,365
|
|
G |
Agtr2 |
angiotensin II receptor, type 2 |
|
IEP |
protein:decreased expression:kidney |
RGD |
PMID:16725227 |
RGD:6903849 |
NCBI chr X:112,119,876...112,124,060
Ensembl chr X:112,120,228...112,124,057
|
|
G |
Ahr |
aryl hydrocarbon receptor |
severity |
ISO |
|
RGD |
PMID:24930766 |
RGD:39939032 |
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
|
|
G |
Akp3 |
alkaline phosphatase 3, intestine, not Mn requiring |
|
ISO |
|
RGD |
PMID:23569246 |
RGD:14349049 |
NCBI chr 9:87,804,680...87,808,715
Ensembl chr 9:87,804,749...87,807,913
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
|
IEP |
|
RGD |
PMID:22824368 |
RGD:38676479 |
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Aldoa |
aldolase, fructose-bisphosphate A |
|
IEP |
|
RGD |
PMID:16930621 |
RGD:1599054 |
NCBI chr 1:181,402,275...181,407,476
Ensembl chr 1:181,402,275...181,406,182
|
|
G |
Alox5 |
arachidonate 5-lipoxygenase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15328337 |
|
NCBI chr 4:149,531,329...149,578,696
Ensembl chr 4:149,531,515...149,578,743
|
|
G |
Apoa1 |
apolipoprotein A1 |
treatment |
ISO IDA |
|
RGD |
PMID:18593575 PMID:23227448 |
RGD:7241573, RGD:7241868 |
NCBI chr 8:46,527,251...46,529,035
Ensembl chr 8:46,527,144...46,529,035
|
|
G |
Apob |
apolipoprotein B |
|
IEP |
|
RGD |
PMID:16719989 |
RGD:1599165 |
NCBI chr 6:30,844,386...30,883,983
Ensembl chr 6:30,844,368...30,892,497
|
|
G |
Apoe |
apolipoprotein E |
|
ISO |
rat model treated with human protein |
RGD |
PMID:9153287 |
RGD:6904216 |
NCBI chr 1:79,353,924...79,357,852
Ensembl chr 1:79,353,916...79,357,932
|
|
G |
Asl |
argininosuccinate lyase |
|
IEP |
|
RGD |
PMID:10652239 |
RGD:1599265 |
NCBI chr12:26,659,664...26,677,136
Ensembl chr12:26,659,565...26,679,662
|
|
G |
Ass1 |
argininosuccinate synthase 1 |
|
IEP |
|
RGD |
PMID:10652239 |
RGD:1599265 |
NCBI chr 3:14,747,355...14,796,909
Ensembl chr 3:14,747,368...14,796,903
|
|
G |
Atf2 |
activating transcription factor 2 |
treatment |
IEP IDA |
protein:increased expression, increased activity:small intestine mucosa |
RGD |
PMID:21641970 PMID:24312512 |
RGD:5135029, RGD:10047418 |
NCBI chr 3:58,718,323...58,795,280
Ensembl chr 3:58,718,332...58,795,236
|
|
G |
Atp5f1a |
ATP synthase F1 subunit alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16741687 |
|
NCBI chr18:71,292,406...71,300,342
Ensembl chr18:71,292,374...71,300,794
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
|
IEP |
mRNA:increased expression:diaphragm |
RGD |
PMID:23940949 |
RGD:10054120 |
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bche |
butyrylcholinesterase |
|
ISO |
|
RGD |
PMID:17657467 |
RGD:5688055 |
NCBI chr 2:158,308,674...158,401,148
Ensembl chr 2:158,307,584...158,401,148
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
|
IEP |
mRNA:decreased expression:diaphragm |
RGD |
PMID:23940949 |
RGD:10054120 |
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
C5ar1 |
complement C5a receptor 1 |
|
IEP |
mRNA:increased expression:lung |
RGD |
PMID:9272704 |
RGD:70679 |
NCBI chr 1:76,948,622...76,959,826
|
|
G |
Casp1 |
caspase 1 |
|
IMP |
|
RGD |
PMID:17384935 |
RGD:2315892 |
NCBI chr 8:2,587,812...2,597,403
Ensembl chr 8:2,587,831...2,597,383
|
|
G |
Casp3 |
caspase 3 |
|
IEP |
mRNA:increased expression:diaphragm |
RGD |
PMID:23940949 |
RGD:10054120 |
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp7 |
caspase 7 |
|
ISO |
|
RGD |
PMID:19168786 |
RGD:5684539 |
NCBI chr 1:255,437,438...255,476,737
Ensembl chr 1:255,437,172...255,476,729
|
|
G |
Casp9 |
caspase 9 |
treatment |
IEP |
|
RGD |
PMID:23214195 |
RGD:10400903 |
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Cbs |
cystathionine beta synthase |
severity |
ISO IEP |
mRNA:increased expression:liver (rat) Protein:increased expression:spleen, lung (mouse) |
RGD |
PMID:27748832 PMID:16100527 PMID:24702258 PMID:27748832 |
RGD:40903019, RGD:40903049, RGD:40903035, RGD:40903019 |
NCBI chr20:9,708,089...9,732,623
Ensembl chr20:9,708,090...9,732,764
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
|
IEP |
protein:increased expression:plasma |
RGD |
PMID:19060786 |
RGD:2307004 |
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
|
|
G |
Ccl5 |
C-C motif chemokine ligand 5 |
|
IEP |
protein:increased expression:plasma |
RGD |
PMID:16215387 |
RGD:2307171 |
NCBI chr10:68,322,826...68,327,380
Ensembl chr10:68,322,829...68,327,377
|
|
G |
Ccr1 |
C-C motif chemokine receptor 1 |
|
ISO |
|
RGD |
PMID:17016504 |
RGD:5688178 |
NCBI chr 8:123,556,286...123,561,841
|
|
G |
Cd14 |
CD14 molecule |
|
IEP |
protein:increased expression:liver, endothelial cell of sinusoid |
RGD |
PMID:12046090 |
RGD:724637 |
NCBI chr18:28,335,522...28,337,383
Ensembl chr18:28,335,340...28,337,261
|
|
G |
Cd40 |
CD40 molecule |
|
ISO |
protein:decreased nitrosylation:macrophage |
RGD |
PMID:20473113 |
RGD:5490974 |
NCBI chr 3:153,790,372...153,805,279
Ensembl chr 3:153,790,449...153,805,534
|
|
G |
Cebpb |
CCAAT/enhancer binding protein beta |
treatment |
IEP ISO |
|
RGD |
PMID:15192048 PMID:14659593 |
RGD:1625687, RGD:40903034 |
NCBI chr 3:156,398,035...156,399,466
Ensembl chr 3:156,397,052...156,399,473
|
|
G |
Cps1 |
carbamoyl-phosphate synthase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16741687 |
|
NCBI chr 9:68,614,153...68,737,037
Ensembl chr 9:68,614,153...68,737,033
|
|
G |
Cs |
citrate synthase |
|
IEP |
protein:increased expression:gastrocnemius |
RGD |
PMID:25674200 |
RGD:329337350 |
NCBI chr 7:758,074...791,421
Ensembl chr 7:758,345...791,421
|
|
G |
Csf3 |
colony stimulating factor 3 |
treatment |
ISO |
|
RGD |
PMID:9514298 |
RGD:11039535 |
NCBI chr10:83,660,787...83,664,569
Ensembl chr10:83,661,207...83,663,603
|
|
G |
Cx3cl1 |
C-X3-C motif chemokine ligand 1 |
|
IEP |
protein:increased expression:atrium endocardium |
RGD |
PMID:19282612 |
RGD:4891965 |
NCBI chr19:10,227,337...10,237,826
Ensembl chr19:10,227,340...10,236,833
|
|
G |
Cxcl1 |
C-X-C motif chemokine ligand 1 |
|
ISO |
mRNA:increased expression:multiple organs |
RGD |
PMID:9766630 |
RGD:5135254 |
NCBI chr14:17,193,364...17,195,143
Ensembl chr14:17,193,365...17,195,215
|
|
G |
Cxcl2 |
C-X-C motif chemokine ligand 2 |
|
ISO |
mRNA:increased expression:multiple organs |
RGD |
PMID:9766630 |
RGD:5135254 |
NCBI chr14:17,181,030...17,183,075
Ensembl chr14:17,181,062...17,183,075
|
|
G |
Cxcl6 |
C-X-C motif chemokine ligand 6 |
|
ISO |
mRNA:increased expression:multiple organs |
RGD |
PMID:9766630 |
RGD:5135254 |
NCBI chr14:17,310,790...17,312,250
Ensembl chr14:17,310,426...17,313,093
|
|
G |
Edn1 |
endothelin 1 |
|
IEP |
mRNA, protein:increased expression:liver (rat) |
RGD |
PMID:11206318 |
RGD:8662297 |
NCBI chr17:22,454,924...22,460,812
Ensembl chr17:22,454,420...22,460,885
|
|
G |
Ep300 |
E1A binding protein p300 |
|
IEP |
associated with Kidney Reperfusion Injury; protein:altered localization:kidney (rat) |
RGD |
PMID:23936185 |
RGD:7257563 |
NCBI chr 7:113,108,476...113,178,529
Ensembl chr 7:113,106,247...113,136,088 Ensembl chr 7:113,106,247...113,136,088
|
|
G |
Ephx2 |
epoxide hydrolase 2 |
|
ISO |
|
RGD |
PMID:19154430 |
RGD:5688360 |
NCBI chr15:40,289,901...40,327,632
Ensembl chr15:40,289,902...40,327,615
|
|
G |
Epo |
erythropoietin |
treatment |
ISO |
|
RGD |
PMID:23214195 |
RGD:10400903 |
NCBI chr12:19,204,258...19,207,948
Ensembl chr12:19,204,508...19,207,946
|
|
G |
F12 |
coagulation factor XII |
|
IEP |
|
RGD |
PMID:11092686 |
RGD:7394782 |
NCBI chr17:9,207,683...9,215,530
Ensembl chr17:9,207,683...9,215,530
|
|
G |
F2 |
coagulation factor II, thrombin |
treatment severity |
IDA ISO IEP |
associated with liver cirrhosis;protein:increased expression:blood plasma (human) associated with liver cirrhosis;protein:increased expression:plasma (human) |
RGD |
PMID:21396682 PMID:10604885 PMID:7615203 PMID:10887118 PMID:9863491 PMID:25396762 PMID:22227956 PMID:20519137 More...
|
RGD:5147765, RGD:40818436, RGD:14974253, RGD:40818427, RGD:14401592, RGD:10449434, RGD:6893482, RGD:5147779 |
NCBI chr 3:77,596,196...77,609,486
Ensembl chr 3:77,596,198...77,609,486
|
|
G |
F3 |
coagulation factor III, tissue factor |
treatment |
IDA ISO |
associated with Protein C Deficiency |
RGD |
PMID:21396682 PMID:20858853 PMID:8956768 |
RGD:5147765, RGD:11341685, RGD:11340208 |
NCBI chr 2:209,827,061...209,838,666
Ensembl chr 2:209,826,959...209,838,668
|
|
G |
F5 |
coagulation factor V |
|
IEP |
|
RGD |
PMID:11092686 |
RGD:7394782 |
NCBI chr13:76,513,509...76,583,106
Ensembl chr13:76,513,255...76,582,317
|
|
G |
F7 |
coagulation factor VII |
treatment |
IEP ISO |
|
RGD |
PMID:11092686 PMID:16378835 |
RGD:7394782, RGD:11041650 |
NCBI chr16:76,489,775...76,500,636
Ensembl chr16:76,489,717...76,500,610
|
|
G |
F8 |
coagulation factor VIII |
|
IEP |
|
RGD |
PMID:11092686 |
RGD:7394782 |
NCBI chr18:140,848...172,330
Ensembl chr18:140,955...171,857
|
|
G |
Fas |
Fas cell surface death receptor |
|
IEP |
mRNA, protein:increased expression:spleen (rat) |
RGD |
PMID:20428798 |
RGD:8662930 |
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
|
|
G |
Fga |
fibrinogen alpha chain |
treatment |
IDA |
|
RGD |
PMID:19295478 |
RGD:11040925 |
NCBI chr 2:168,374,120...168,381,523
Ensembl chr 2:168,374,120...168,381,528
|
|
G |
Foxp3 |
forkhead box P3 |
|
IEP |
protein:increased expression:intestinal mucosa |
RGD |
PMID:19998507 |
RGD:38455980 |
NCBI chr X:14,908,494...14,924,994
Ensembl chr X:14,908,494...14,923,838
|
|
G |
Gch1 |
GTP cyclohydrolase 1 |
treatment |
IEP |
mRNA:increased expression:lung associated with liver cirrhosis |
RGD |
PMID:9388472 PMID:16845913 PMID:14647062 |
RGD:329961576, RGD:401793756, RGD:401700399 |
NCBI chr15:20,404,267...20,437,727
Ensembl chr15:20,402,527...20,437,698
|
|
G |
Gfer |
growth factor, augmenter of liver regeneration |
|
IEP |
|
RGD |
PMID:23073658 |
RGD:9685733 |
NCBI chr10:13,718,489...13,721,782
Ensembl chr10:13,718,489...13,720,869
|
|
G |
Ghr |
growth hormone receptor |
|
IEP |
mRNA:decreased expression:liver |
RGD |
PMID:12654216 PMID:12217886 |
RGD:2307380, RGD:625688 |
NCBI chr 2:52,541,452...52,804,960
Ensembl chr 2:52,542,594...52,804,735
|
|
G |
Gpt |
glutamic--pyruvic transaminase |
treatment |
IEP |
|
RGD |
PMID:25514429 |
RGD:401717525 |
NCBI chr 7:110,295,599...110,300,134
Ensembl chr 7:108,416,642...108,419,494
|
|
G |
Gsr |
glutathione-disulfide reductase |
treatment |
IEP |
|
RGD |
PMID:25469663 |
RGD:10401928 |
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
|
|
G |
Hmgb1 |
high mobility group box 1 |
|
IEP |
protein:increased expression:heart, serum |
RGD |
PMID:18503231 |
RGD:10402065 |
NCBI chr12:5,972,950...5,979,658
Ensembl chr12:5,901,586...5,978,565 Ensembl chr16:5,901,586...5,978,565
|
|
G |
Hmox1 |
heme oxygenase 1 |
treatment |
IEP |
|
RGD |
PMID:21396999 |
RGD:10755715 |
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Hsf1 |
heat shock transcription factor 1 |
treatment |
IDA |
|
RGD |
PMID:25571843 |
RGD:10402404 |
NCBI chr 7:108,196,040...108,223,011
Ensembl chr 7:108,196,056...108,223,011
|
|
G |
Hspa9 |
heat shock protein family A (Hsp70) member 9 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16741687 |
|
NCBI chr18:26,536,131...26,554,294
Ensembl chr18:26,535,798...26,554,292
|
|
G |
Hspd1 |
heat shock protein family D (Hsp60) member 1 |
|
IEP ISO |
mRNA, protein:increased expression:medulla oblongata CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:16741687 PMID:16675490 |
RGD:1624232 |
NCBI chr 9:56,579,195...56,590,011
Ensembl chr 9:56,579,201...56,589,662
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
|
IEP |
protein:increased expression:lung (rat) |
RGD |
PMID:19776691 |
RGD:4145502 |
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
|
|
G |
Ido1 |
indoleamine 2,3-dioxygenase 1 |
|
ISO |
|
RGD |
PMID:24930766 PMID:28077574 |
RGD:39939032, RGD:39939117 |
NCBI chr16:67,430,654...67,442,726
Ensembl chr16:67,430,578...67,442,730
|
|
G |
Ido2 |
indoleamine 2,3-dioxygenase 2 |
|
ISO |
|
RGD |
PMID:24930766 |
RGD:39939032 |
NCBI chr16:67,459,158...67,498,052
Ensembl chr16:67,459,190...67,496,324
|
|
G |
Ifng |
interferon gamma |
|
IEP |
protein:increased expression:serum: |
RGD |
PMID:9195172 |
RGD:10755747 |
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
|
|
G |
Igf1 |
insulin-like growth factor 1 |
|
IEP |
mRNA, protein:decreased expression:liver, serum |
RGD |
PMID:18492809 PMID:12217886 |
RGD:10402757, RGD:625688 |
NCBI chr 7:22,282,895...22,361,972
Ensembl chr 7:22,282,930...22,359,296
|
|
G |
Igfals |
insulin-like growth factor binding protein, acid labile subunit |
|
IEP |
|
RGD |
PMID:12217886 |
RGD:625688 |
NCBI chr10:13,897,468...13,903,920
Ensembl chr10:13,898,395...13,902,677
|
|
G |
Igfbp1 |
insulin-like growth factor binding protein 1 |
|
IEP |
|
RGD |
PMID:12217886 |
RGD:625688 |
NCBI chr14:82,047,415...82,052,482
Ensembl chr14:82,047,415...82,052,482
|
|
G |
Igfbp3 |
insulin-like growth factor binding protein 3 |
|
IEP |
mRNA, protein:decreased expression:liver, serum |
RGD |
PMID:18492809 |
RGD:10402757 |
NCBI chr14:82,056,347...82,064,083
Ensembl chr14:82,056,347...82,064,083
|
|
G |
Igfbp5 |
insulin-like growth factor binding protein 5 |
|
IEP |
|
RGD |
PMID:12217886 |
RGD:625688 |
NCBI chr 9:74,452,371...74,464,953
Ensembl chr 9:74,448,382...74,465,156
|
|
G |
Il10 |
interleukin 10 |
treatment |
IEP ISO |
protein:increased expression:plasma |
RGD |
PMID:19302852 PMID:27943364 PMID:28664613 |
RGD:2311055, RGD:14975170, RGD:14975137 |
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
|
|
G |
Il13 |
interleukin 13 |
treatment |
ISO |
|
RGD |
PMID:10674721 |
RGD:8549626 |
NCBI chr10:37,790,130...37,792,687
Ensembl chr10:37,790,130...37,792,737
|
|
G |
Il1a |
interleukin 1 alpha |
|
ISO IEP |
protein:increased expression:plasma |
RGD |
PMID:9636192 PMID:22426124 |
RGD:6907109, RGD:7794786 |
NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822
|
|
G |
Il1b |
interleukin 1 beta |
|
IEP |
protein:increased expression:plasma |
RGD |
PMID:17201737 |
RGD:1626625 |
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il1rn |
interleukin 1 receptor antagonist |
treatment |
IEP ISO |
mRNA:increased expression:lung, spleen, liver (rat) |
RGD |
PMID:1385928 PMID:8855299 |
RGD:8551846, RGD:11522760 |
NCBI chr 3:7,111,567...7,127,451
Ensembl chr 3:7,111,550...7,127,445
|
|
G |
Il6 |
interleukin 6 |
|
IDA IEP |
associated with Diabetes Mellitus, Experimental; Protein:increased expression:extracellular space (rat) protein:increased expression:serum (rat) |
RGD |
PMID:19449282 PMID:22227956 PMID:21396682 |
RGD:2307179, RGD:6893482, RGD:5147765 |
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Irak3 |
interleukin-1 receptor-associated kinase 3 |
|
ISO |
mRNA, protein:increased expression:blood (human) |
RGD |
PMID:17982103 |
RGD:36049802 |
NCBI chr 7:55,653,949...55,714,371
Ensembl chr 7:55,653,962...55,713,121
|
|
G |
Irs1 |
insulin receptor substrate 1 |
|
ISO |
protein:increased tyrosine nitration, decreased tyrosine phosphorylation:skeletal muscle |
RGD |
PMID:21206533 |
RGD:6483008 |
NCBI chr 9:83,552,964...83,605,797
Ensembl chr 9:83,548,944...83,606,122
|
|
G |
Itga2b |
integrin subunit alpha 2b |
|
IMP |
|
RGD |
PMID:15280099 |
RGD:2316360 |
NCBI chr10:87,408,532...87,426,055
Ensembl chr10:87,408,536...87,426,168
|
|
G |
Itgb3 |
integrin subunit beta 3 |
|
IMP |
|
RGD |
PMID:15280099 |
RGD:2316360 |
NCBI chr10:89,509,917...89,564,679
Ensembl chr10:89,509,989...89,564,679
|
|
G |
Keap1 |
Kelch-like ECH-associated protein 1 |
|
ISO |
|
RGD |
PMID:22609006 |
RGD:6892951 |
NCBI chr 8:28,044,555...28,054,042
Ensembl chr 8:19,768,375...19,777,862
|
|
G |
Lbp |
lipopolysaccharide binding protein |
treatment |
IEP ISO |
mRNA:increased expression:hepatocyte |
RGD |
PMID:8418776 PMID:8593028 PMID:16307218 |
RGD:9685191, RGD:9685196, RGD:9685193 |
NCBI chr 3:146,953,889...146,981,032
Ensembl chr 3:146,954,015...146,981,586
|
|
G |
Lcn2 |
lipocalin 2 |
|
ISO |
mRNA:increased expression:brain,liver |
RGD |
PMID:21943033 |
RGD:126779582 |
NCBI chr 3:15,680,688...15,684,033
Ensembl chr 3:15,680,687...15,684,095
|
|
G |
Map2 |
microtubule-associated protein 2 |
|
ISO |
mRNA, protein:decreased expression:neuron |
RGD |
PMID:21421895 |
RGD:6483086 |
NCBI chr 9:67,723,422...67,981,886
Ensembl chr 9:67,723,371...67,979,809
|
|
G |
Mapk14 |
mitogen activated protein kinase 14 |
treatment |
IEP IDA |
protein:increased activity:small intestine mucosa |
RGD |
PMID:21641970 PMID:24312512 |
RGD:5135029, RGD:10047418 |
NCBI chr20:6,749,646...6,810,590
Ensembl chr20:6,749,670...6,810,589
|
|
G |
Mapk8 |
mitogen-activated protein kinase 8 |
|
IEP |
protein:increased phophorylation:hippocampus (rat) |
RGD |
PMID:12207162 |
RGD:150340687 |
NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981
|
|
G |
Mc4r |
melanocortin 4 receptor |
|
IEP |
mRNA:increased expression:paraventricular nucleus (rat) |
RGD |
PMID:21343543 |
RGD:6484214 |
NCBI chr18:60,419,832...60,421,719
Ensembl chr18:60,419,832...60,421,719
|
|
G |
Mif |
macrophage migration inhibitory factor |
|
IEP |
protein:increased expression:plasma |
RGD |
PMID:16601957 |
RGD:1641983 |
NCBI chr20:12,790,919...12,791,784
Ensembl chr20:12,790,902...12,799,504 Ensembl chr 4:12,790,902...12,799,504
|
|
G |
Mir146a |
microRNA 146a |
treatment |
ISO |
miRNA:increased expression:spleen (mouse) |
RGD |
PMID:30867482 |
RGD:34888227 |
NCBI chr10:27,848,516...27,848,610
Ensembl chr10:27,848,516...27,848,610
|
|
G |
Mir155 |
microRNA 155 |
treatment |
ISO |
associated with familial hyperlipidemia |
RGD |
PMID:28970282 PMID:28264607 PMID:29079998 PMID:29979224 |
RGD:21079445, RGD:24922204, RGD:21081539, RGD:21081538 |
NCBI chr11:37,261,114...37,261,178
Ensembl chr11:23,774,654...23,774,718
|
|
G |
Mme |
membrane metallo-endopeptidase |
severity |
IMP |
|
RGD |
PMID:11078421 |
RGD:13801040 |
NCBI chr 2:147,686,913...147,803,808
Ensembl chr 2:147,722,086...147,803,792
|
|
G |
Mmp3 |
matrix metallopeptidase 3 |
|
IEP |
|
RGD |
PMID:17083784 |
RGD:2290426 |
NCBI chr 8:4,640,397...4,653,963
Ensembl chr 8:4,640,416...4,653,961
|
|
G |
Mt2 |
metallothionein 2 |
|
IEP |
mRNA:increased expression:liver (rat) |
RGD |
PMID:22100509 |
RGD:6483852 |
NCBI chr19:10,832,009...10,832,783
Ensembl chr19:10,832,002...10,832,784
|
|
G |
Mt3 |
metallothionein 3 |
|
IEP |
|
RGD |
PMID:12135776 |
RGD:10412330 |
NCBI chr19:10,848,754...10,850,158
Ensembl chr19:10,848,755...10,850,158
|
|
G |
Muc2 |
mucin 2, oligomeric mucus/gel-forming |
|
IEP |
|
RGD |
PMID:19099858 |
RGD:7349370 |
NCBI chr 1:196,799,494...196,831,740
Ensembl chr 1:196,799,517...196,831,756
|
|
G |
Myh6 |
myosin heavy chain 6 |
|
IEP |
|
RGD |
PMID:7874842 |
RGD:12792976 |
NCBI chr15:28,418,120...28,442,316
Ensembl chr15:28,417,616...28,441,720
|
|
G |
Myh7 |
myosin heavy chain 7 |
|
IEP |
|
RGD |
PMID:7874842 |
RGD:12792976 |
NCBI chr15:28,446,550...28,469,888
Ensembl chr15:28,446,550...28,468,217
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
treatment |
IEP |
|
RGD |
PMID:26646455 |
RGD:42722616 |
NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:60,594,242...60,621,737
|
|
G |
Nfkbia |
NFKB inhibitor alpha |
exacerbates treatment |
ISO |
|
RGD |
PMID:19098124 PMID:10229101 |
RGD:126908017, RGD:126928139 |
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
|
|
G |
Nos2 |
nitric oxide synthase 2 |
|
IEP ISO IDA |
mRNA, protein:increased expression:intestine CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:12620498 PMID:16787348 PMID:20519137 |
RGD:4891470, RGD:5147779 |
NCBI chr10:64,313,335...64,349,221
Ensembl chr10:63,815,308...63,851,210
|
|
G |
Nos3 |
nitric oxide synthase 3 |
|
IEP |
protein:increased expression:aorta (rat) |
RGD |
PMID:10462376 |
RGD:7794732 |
NCBI chr 4:10,793,834...10,814,170
Ensembl chr 4:10,793,834...10,814,166
|
|
G |
Npy |
neuropeptide Y |
treatment |
IDA |
|
RGD |
PMID:15342191 |
RGD:1580787 |
NCBI chr 4:78,881,294...78,888,495
Ensembl chr 4:78,881,264...78,888,495
|
|
G |
Nr3c1 |
nuclear receptor subfamily 3, group C, member 1 |
|
IDA |
|
RGD |
PMID:15640646 |
RGD:4892561 |
NCBI chr18:31,522,783...31,644,508
Ensembl chr18:31,271,681...31,393,375
|
|
G |
Otc |
ornithine transcarbamylase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16741687 |
|
NCBI chr X:12,453,834...12,529,954
Ensembl chr X:12,453,834...12,566,918
|
|
G |
Pck1 |
phosphoenolpyruvate carboxykinase 1 |
|
IEP |
|
RGD |
PMID:19268478 PMID:12217886 |
RGD:10427879, RGD:625688 |
NCBI chr 3:161,930,256...161,936,205
Ensembl chr 3:161,930,256...161,936,191
|
|
G |
Pck2 |
phosphoenolpyruvate carboxykinase 2 (mitochondrial) |
|
IEP |
mRNA,protein:decreased expression,decreased activity:liver: |
RGD |
PMID:19268478 |
RGD:10427879 |
NCBI chr15:29,027,891...29,036,729
Ensembl chr15:29,027,894...29,037,283
|
|
G |
Pcsk1 |
proprotein convertase subtilisin/kexin type 1 |
|
IEP |
|
RGD |
PMID:16337011 |
RGD:6483567 |
NCBI chr 2:4,395,543...4,442,434
Ensembl chr 2:4,395,543...4,442,434
|
|
G |
Pcsk2 |
proprotein convertase subtilisin/kexin type 2 |
|
IEP |
|
RGD |
PMID:16337011 |
RGD:6483567 |
NCBI chr 3:130,880,422...131,183,127
Ensembl chr 3:130,880,422...131,183,127
|
|
G |
Pecam1 |
platelet and endothelial cell adhesion molecule 1 |
|
ISO |
|
RGD |
PMID:22119535 |
RGD:6771174 |
NCBI chr10:91,590,521...91,652,279
Ensembl chr10:91,590,521...91,652,116
|
|
G |
Pf4 |
platelet factor 4 |
treatment |
IEP |
|
RGD |
PMID:20601223 |
RGD:329901905 |
NCBI chr14:17,298,304...17,299,220
Ensembl chr14:17,298,308...17,299,365
|
|
G |
Pgf |
placental growth factor |
|
ISO |
protein:increased expression:multiple |
RGD |
PMID:16702604 |
RGD:6483601 |
NCBI chr 6:104,816,102...104,826,685
Ensembl chr 6:104,816,104...104,826,685
|
|
G |
Pla2g7 |
phospholipase A2 group VII |
|
IEP |
protein:increased expression: : |
RGD |
PMID:10748027 |
RGD:7248791 |
NCBI chr 9:17,362,214...17,404,476
Ensembl chr 9:17,362,225...17,404,476
|
|
G |
Plat |
plasminogen activator, tissue type |
treatment |
ISO |
|
RGD |
PMID:9091588 |
RGD:11541073 |
NCBI chr16:69,240,582...69,265,177
Ensembl chr16:69,240,585...69,268,223
|
|
G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
IEP |
protein:increased expression:small intestine mucosa |
RGD |
PMID:21641970 |
RGD:5135029 |
NCBI chr 4:150,095,743...150,221,104
Ensembl chr 4:148,423,194...148,548,468
|
|
G |
Prkaa1 |
protein kinase AMP-activated catalytic subunit alpha 1 |
|
ISO |
mRNA:decreased expression:epididymal fat pad |
RGD |
PMID:20421294 |
RGD:6484543 |
NCBI chr 2:54,240,298...54,275,978
Ensembl chr 2:54,240,137...54,275,978
|
|
G |
Prkn |
parkin RBR E3 ubiquitin protein ligase |
|
ISO |
protein:increased expression:liver, mitochondrion (mouse) |
RGD |
PMID:28615325 |
RGD:13432559 |
NCBI chr 1:48,688,651...49,882,520
Ensembl chr 1:48,690,556...49,882,555
|
|
G |
Proc |
protein C, inactivator of coagulation factors Va and VIIIa |
treatment |
ISO |
|
RGD |
PMID:18205901 PMID:23170801 |
RGD:11100030, RGD:11100034 |
NCBI chr18:23,764,367...23,774,816
Ensembl chr18:23,764,368...23,775,133
|
|
G |
Ptafr |
platelet-activating factor receptor |
treatment |
IMP |
|
RGD |
PMID:2178565 |
RGD:10041063 |
NCBI chr 5:144,765,770...144,795,057
Ensembl chr 5:144,765,976...144,795,251
|
|
G |
Ptger4 |
prostaglandin E receptor 4 |
|
IEP |
protein:increased expression:paraventricular hypothalamic nucleus parvicellular division (rat) |
RGD |
PMID:11058222 |
RGD:10043329 |
NCBI chr 2:54,330,563...54,347,451
Ensembl chr 2:54,335,424...54,346,670
|
|
G |
Ptgis |
prostaglandin I2 synthase |
treatment |
IMP |
|
RGD |
PMID:11076704 |
RGD:401960076 |
NCBI chr 3:155,928,564...155,964,228
Ensembl chr 3:155,916,412...155,965,451
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
IEP |
|
RGD |
PMID:21641970 |
RGD:5135029 |
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Ren |
renin |
|
ISO IEP |
protein:increased activity:blood plasma (mouse) protein:increased activity:blood plasma (rat) |
RGD |
PMID:30027346 PMID:16512638 |
RGD:125097481, RGD:125097499 |
NCBI chr13:44,796,260...44,807,491
Ensembl chr13:44,796,091...44,807,489
|
|
G |
Serpinc1 |
serpin family C member 1 |
treatment |
ISO IDA IEP |
|
RGD |
PMID:16457847 PMID:21396682 PMID:20519137 PMID:15995859 |
RGD:1599326, RGD:5147765, RGD:5147779, RGD:1599332 |
NCBI chr13:73,257,208...73,271,476
Ensembl chr13:73,257,179...73,284,293
|
|
G |
Serpine1 |
serpin family E member 1 |
treatment |
IEP IDA |
|
RGD |
PMID:21396682 PMID:25396762 |
RGD:5147765, RGD:10449434 |
NCBI chr12:19,601,272...19,611,657
Ensembl chr12:19,601,272...19,611,657
|
|
G |
Serpinf1 |
serpin family F member 1 |
|
ISO |
protein:increased expression:plasma (human) |
RGD |
PMID:12386642 |
RGD:36174005 |
NCBI chr10:60,250,198...60,262,593
Ensembl chr10:60,249,708...60,262,646
|
|
G |
Serping1 |
serpin family G member 1 |
treatment |
ISO |
|
RGD |
PMID:18652771 |
RGD:8661643 |
NCBI chr 3:69,842,726...69,852,583
Ensembl chr 3:69,842,739...69,852,034
|
|
G |
Slc18a3 |
solute carrier family 18 member A3 |
|
IEP |
protein:decreased expression:parietal cortex |
RGD |
PMID:17306796 |
RGD:5686693 |
NCBI chr16:7,713,630...7,716,491
|
|
G |
Slc22a1 |
solute carrier family 22 member 1 |
treatment |
IDA |
|
RGD |
PMID:18313662 |
RGD:7243881 |
NCBI chr 1:48,076,657...48,103,679
Ensembl chr 1:48,076,666...48,103,678
|
|
G |
Slc22a2 |
solute carrier family 22 member 2 |
treatment |
IDA |
|
RGD |
PMID:18313662 |
RGD:7243881 |
NCBI chr 1:48,121,061...48,163,268
Ensembl chr 1:48,121,061...48,163,268
|
|
G |
Slc38a3 |
solute carrier family 38, member 3 |
|
IEP |
|
RGD |
PMID:20036385 |
RGD:9999227 |
NCBI chr 8:108,323,889...108,339,959
Ensembl chr 8:108,323,894...108,339,988
|
|
G |
Slc38a5 |
solute carrier family 38, member 5 |
|
IEP |
|
RGD |
PMID:20036385 |
RGD:9999227 |
NCBI chr X:14,213,727...14,222,498
Ensembl chr X:14,213,729...14,222,498
|
|
G |
Slc7a5 |
solute carrier family 7 member 5 |
|
IEP |
|
RGD |
PMID:26337286 |
RGD:151361133 |
NCBI chr19:49,935,220...49,963,823
Ensembl chr19:49,935,220...49,963,823
|
|
G |
Slpi |
secretory leukocyte peptidase inhibitor |
|
IEP |
|
RGD |
PMID:25466948 |
RGD:9999425 |
NCBI chr 3:153,082,208...153,084,457
Ensembl chr 3:153,082,369...153,084,453
|
|
G |
Socs1 |
suppressor of cytokine signaling 1 |
|
ISO |
mRNA:increased expression:liver, skeletal muscle |
RGD |
PMID:15169905 |
RGD:2298923 |
NCBI chr10:4,882,651...4,884,342
Ensembl chr10:4,882,560...4,884,383
|
|
G |
Socs3 |
suppressor of cytokine signaling 3 |
|
ISO IEP |
mRNA:increased expression:liver, skeletal muscle |
RGD |
PMID:15169905 PMID:12217886 |
RGD:2298923, RGD:625688 |
NCBI chr10:103,193,909...103,197,322
Ensembl chr10:103,193,537...103,197,787
|
|
G |
Sod2 |
superoxide dismutase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16741687 |
|
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
|
|
G |
Sparc |
secreted protein acidic and cysteine rich |
|
IEP |
mRNA, protein:decreased expression:kidney |
RGD |
PMID:10703670 |
RGD:2300026 |
NCBI chr10:39,516,394...39,538,252
Ensembl chr10:39,516,406...39,538,396
|
|
G |
Stat5b |
signal transducer and activator of transcription 5B |
|
IDA |
protein:decreased tyrosine phosphorylation:liver |
RGD |
PMID:17327369 |
RGD:1601383 |
NCBI chr10:85,704,841...85,775,856
Ensembl chr10:85,705,670...85,775,668
|
|
G |
Tbxa2r |
thromboxane A2 receptor |
|
IDA IMP |
|
RGD |
PMID:15647606 PMID:2580129 |
RGD:1601450, RGD:11059531 |
NCBI chr 7:8,383,347...8,390,753
Ensembl chr 7:8,383,378...8,388,176
|
|
G |
Tbxas1 |
thromboxane A synthase 1 |
|
IDA |
|
RGD |
PMID:15647606 |
RGD:1601450 |
NCBI chr 4:67,664,963...67,837,096
Ensembl chr 4:67,665,007...67,837,096
|
|
G |
Tdo2 |
tryptophan 2,3-dioxygenase |
severity |
ISO |
|
RGD |
PMID:24930766 |
RGD:39939032 |
NCBI chr 2:167,269,581...167,287,511
Ensembl chr 2:167,269,579...167,287,511
|
|
G |
Tfpi |
tissue factor pathway inhibitor |
treatment |
ISO |
|
RGD |
PMID:17537762 |
RGD:11062086 |
NCBI chr 3:69,533,156...69,582,547
Ensembl chr 3:69,533,156...69,576,880
|
|
G |
Thbd |
thrombomodulin |
|
IEP ISO |
mRNA:decreased expression:endothelial cell |
RGD |
PMID:12611420 PMID:20348393 PMID:19487933 |
RGD:1601652, RGD:5685037, RGD:5684988 |
NCBI chr 3:135,863,366...135,867,018
Ensembl chr 3:135,862,835...135,867,193
|
|
G |
Timp3 |
TIMP metallopeptidase inhibitor 3 |
|
IEP |
|
RGD |
PMID:17083784 |
RGD:2290426 |
NCBI chr 7:17,520,827...17,571,850
Ensembl chr 7:17,521,919...17,571,839
|
|
G |
Tlr2 |
toll-like receptor 2 |
treatment |
IDA ISO |
associated with liver cirrhosis |
RGD |
PMID:22172266 PMID:12610323 |
RGD:7241094, RGD:597538466 |
NCBI chr 2:169,200,620...169,206,819
Ensembl chr 2:169,197,419...169,206,630
|
|
G |
Tlr4 |
toll-like receptor 4 |
treatment disease_progression |
IDA ISO |
mRNA:increased expression:liver: |
RGD |
PMID:22172266 PMID:23977376 PMID:23977376 |
RGD:7241094, RGD:14697731, RGD:14697731 |
NCBI chr 5:80,145,867...80,159,501
Ensembl chr 5:80,145,826...80,159,628
|
|
G |
Tnf |
tumor necrosis factor |
treatment |
IEP ISO IDA |
protein:increased expression:plasma XCO:0000822 JTE-607 associated with liver cirrhosis protein:increased expression:plasma (rat) |
RGD |
PMID:17324147 PMID:10493164 PMID:15242491 PMID:18078960 PMID:8283134 PMID:12813371 PMID:21396682 PMID:20519137 More...
|
RGD:4891465, RGD:40903016, RGD:38501090, RGD:15023464, RGD:14995443, RGD:14995427, RGD:5147765, RGD:5147779 |
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Trem1 |
triggering receptor expressed on myeloid cells 1 |
treatment |
ISO |
|
RGD |
PMID:21507332 PMID:15585833 |
RGD:126925982, RGD:126928122 |
NCBI chr 9:12,763,819...12,779,285
Ensembl chr 9:12,763,819...12,779,203
|
|
G |
Vcam1 |
vascular cell adhesion molecule 1 |
|
IEP |
mRNA:increased expression:brain: |
RGD |
PMID:20061033 |
RGD:7240511 |
NCBI chr 2:204,038,120...204,057,852
Ensembl chr 2:204,038,114...204,057,958
|
|
G |
Vwf |
von Willebrand factor |
|
IEP |
protein:increased expression:endothelial cell: |
RGD |
PMID:2650559 |
RGD:11079230 |
NCBI chr 4:158,360,152...158,491,539
Ensembl chr 4:158,360,152...158,491,539
|
|
|
G |
Gch1 |
GTP cyclohydrolase 1 |
treatment |
IDA |
|
RGD |
PMID:8602831 |
RGD:329961578 |
NCBI chr15:20,404,267...20,437,727
Ensembl chr15:20,402,527...20,437,698
|
|
G |
Htr2a |
5-hydroxytryptamine receptor 2A |
treatment |
| |